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ABBREVIATIONS 
 
A    adenosine 
Amp    ampicillin 
APC    allophycocyanin 
BCR    B cell receptor 
β-me    β-mercaptoethanol 
bp    base pair 
B4    Bruce-4 
BSA    bovine serum albumin 
C    cytosine 
°C    temperature in degrees Celsius 
CD    cluster of differentiation 
cDNA    complementary DNA 
cpm    counts per minute 
Cre    site-specific recombinase  
C region    constant region 
Cyc    cychrome 
dNTP    desoxyribonucleotide-triphosphate 
DMEM   Dulbecco’s modified Eagle medium 
DMSO    Dimethyl sulfoxide 
DNA    desoxyribonucleic acid 
ds    double-stranded 
DTT    1,4-Dithio- DL-threitol 
E. coli    Escherichia coli 
EDTA    ethylene-diaminetetraacetic acid 
EF    embryonic fibroblasts 
ES    embryonic stem 
EtBr    ethidium bromide 
FACS    fluorescence activated cell sorting 
FCS    foetal calf serum 
FITC    fluorescein-isothiocyanate 
Flp    site-specific recombinase, product of yeast FLP1-gene 
FRT    Flp recombination target 
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g    gram 
GANC    ganciclovir 
G418    geneticin sulfate 
h    hour/s 
HEPES   N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
Ig    immunoglobulin 
i.p.    intraperitoneally 
ITAM    immunoreceptor tyrosine-based activation motifs 
kb    kilobase pairs 
kD/ kDa   kilodalton 
L    liter 
LA    long arm of homology 
LB    Luria-Bertani medium 
LIF    leukaemia inhibitory facto 
loxP    recognition sequence for Cre  
M    molar 
MHC    major histocompatibility locus 
min    minute 
ml    milliliter 
mM    millimolar 
µl    microliter 
µM    micromolar 
MCS    multiple cloning site 
MMC    mitomycin C 
NaCl    sodium chloride 
NaOH    sodium hydroxide 
neo    neomycin resistance gene 
OD    optical density 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PE    phycoerythrine 
PIPES    Piperazine-N,N’-bis(2-ethanesulfonic acid) 
RNA    ribonucleic acid 
rpm     revolutions per minute 
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RT    room temperature 
RU    relative units 
s    second 
SA    short arm of homology 
SDS    sodium dodecyl sulfate 
ss    single-stranded 
SSC    sodium chloride/ sodium citrate buffer 
TAE    Tris-acetic acid-EDTA buffer 
Taq Pol   polymerase from Thermus aquaticus 
TCR    T cell receptor 
TE    Tris-EDTA buffer 
Tris    2-amino-2-(hydroxymethyl-)1,3-propandiole 
TWEEN   polyoxyethylene-sorbitan-monolaureate 
U    units 
UV    ultraviolet 
V    volts 
V region   variable region 
v/v    volume per volume 
w/v    weight per volume 
wt    wild type 
X-Gal    5-Bromo-4-chloro-3-indolyle/β-galactopyranoside 
5’    five prime end of DNA sequences 
3’    three prime end of DNA sequences 
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1 INTRODUCTION 
B cells are an important component of adaptive immunity. They produce and secrete 
millions of different antibody molecules, each of which recognizes a different (foreign) 
antigen. The fact that B lymphocytes express a very large repertoire of antibodies is due to the 
complex mechanism of V(D)J recombination of immunoglobulin (Ig) genes as well as other 
processes including somatic hypermutation, gene conversion and class switch recombination. 
On the other hand, these development processes are tightly controlled, where over 75% of the 
developing cells become apoptotic because of inappropriate immunoglobulin gene 
rearrangements resulting in recognition of self antigens or lack of signal transduction through 
newly formed BCR. (Ollila and Vihinen, 2005) 
1.1 B Cell Development  
B-lymphocytes follow a highly ordered program of development in the bone marrow 
(BM) (Fig.1), beginning with the commitment of lymphoid progenitors to the B lineage and 
the somatic recombination of heavy chain (HC) Ig alleles. After an initial rearrangement of 
diversity (DH) to joining (JH) gene segments, pro-B cells rearrange one of many upstream 
variable (VH) region segments to the D-JH segment, creating the V(D)J joint. Cells with a 
productive protein-encoding HC rearrangement express the HC together with the invariant 
surrogate Ig light chains VpreB and λ5 to form a pre-B cell receptor (Pre-BCR).  Upon 
expression of the pre-BCR, cells undergo clonal expansion before initiation of rearrangements 
at the light chain (LC) loci (Espeli et al., 2006; Jung et al., 2006). A productive LC 
rearrangement results in the cell surface expression of IgM, defining entry into the immature 
B cell stage. A major selection event befalls these immature B cells in the BM where they 
interact with self-Ag. Self-reactive B cells are extinguished by three well-characterized 
mechanisms: receptor editing, apoptosis, and anergy. Throughout this process, appropriate 
BCR signals are required for B cell development and survival (Edry and Melamed, 2004). The 
B cells with aberrant BCR signals are deleted during positive and negative selection, which 
ensures the generation of a functionally competent, non-autoimmune repertoire. 
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Fig.1 Receptor editing is activated throughout B lymphopoiesis. Selection checkpoints mediated by the pre-BCR 
or the BCR are specified in the schematic. B cells that fail to fulfill appropriate receptor requirements stimulate 
receptor editing and undergo secondary recombination (Edry and Melamed, 2004). 
1.1.1 Regulation of B Cell Development by the Pre-BCR (positive selection) 
VH to DHJH rearrangement is initiated in the transition from pre-B I to large pre-B II 
cells (Rolink et al., 2001). When an in-frame VHDHJH rearrangement occurs, the subsequently 
expressed µH chain protein can pair with the surrogate light chain (SL) components λ5 and 
VpreB. Upon association with the signal-transducing Igα and Igβ subunits, the pre-BCR 
complex is formed and can be active at the cell surface.  
About 10% of pre-B I cells in the bone marrow express µH chain in the cytoplasm. Not 
all of these µH chains, however, are capable of forming a pre-BCR (Martensson et al., 2002). 
At the transition from pre-B I to pre-B II, those cells expressing a µH chain capable of 
forming a pre-BCR are positively selected and enter into cellular division and expansion. 
(Melchers, 2005; Zhang et al., 2004). 
1.1.2 Regulation of B Cell Development by the BCR (Negative Selection) 
The next checkpoint in B cell development occurs during progression from immature to 
mature B cell stages, where encountering antigen capable of cross-linking BCR typically 
leads to one of three results in immature B cells: (a) cells are eliminated (clonal deletion); (b) 
cells are rendered non-responsive and short lived (anergic); or (c) cells revise their BCR to 
eliminate self-reactivity (editing) (Hardy and Hayakawa, 2001). High-affinity interactions 
with membrane-bound antigen result in deletion, whereas lower-affinity interactions and 
soluble antigens will result in editing or anergy (Benschop et al., 1999; Lang et al., 1996).  
Immature B cells, which have not been negatively selected in the BM after exposure to 
self antigen, may migrate from the BM and through the terminal branches of central arterioles 
into the spleen. These splenic immature B cells, which will only survive for 4 days, 
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differentiate into mature B cells with a lifespan of around 15 weeks (Rolink et al., 1998). In 
the BM, however, 90% of the immature B cells will be negatively selected and lost before 
migration to the spleen. 
As pre-BCR signaling results in a transient down-regulation of recombination activating 
gene (RAG) expression (Grawunder et al., 1995), production of a BCR appears critical in 
final cessation of Rag expression, as well as in Ig light chain rearrangement. Hence, 
productive B cell development requires expression of a light chain that can efficiently pair 
with a particular HC to form a cell surface BCR. However, the resulting BCR must not signal 
above some critical threshold (Lang et al., 1996). Otherwise, it appears that Rag expression 
continues, allowing further light chain kappaV genes to rearrange and produce alternative 
light chains to effectively pair with HC. In order to successfully generate a non-autoreactive 
BCR, this light chain editing process can continue on both kappa alleles and eventually 
proceed to the second light chain locus, resulting in lambda light chain expression (Tiegs et 
al., 1993).  
1.2 The B Cell Receptor Complex 
The B cell antigen receptor (BCR) is a hetero-oligomeric structure composed of antigen 
binding membrane immunoglobulin, and transducer-transporter substructures. The transducer-
transporter substructure is composed of disulfide-linked dimers of immunoglobulin (Ig)α and 
Igβ subunits. Naive B cells express BCRs that contain H chains of µ and δ (IgM and IgD) as 
antigen receptors, but after contact with antigen they can switch and use the membrane forms 
of γ, ε, and α (IgG, IgA, or IgE). 
1.2.1 IgM versus IgG1 B Cell Receptor 
While the Ig heavy (H) chains of the classes γ, ε and α carry evolutionarily conserved 
cytoplasmic tails of 14 to 28 amino acids, such structures are lacking in µ and δ chains 
(Geisberger et al., 2003; Neuberger et al., 1989; Reth, 1994). As the latter are expressed in 
developing and mature naïve B cells, the signaling function of the B cell antigen receptor 
(BCR) on those cells is thought to rely entirely on the cytoplasmic tails of the BCR-associated 
Igα/β heterodimer. However, in the generation of B cell memory, most of the antigen-
activated B cells participating in the response switch to the expression of other antibody 
isotypes, and the BCR on these cells acquire the cytoplasmic tail of the newly expressed IgH 
chain as an additional signaling module. The functional importance of this module has 
become apparent in experiments in which the gene segments encoding the cytoplasmic tails of 
the constant (C) regions of the γ1 and ε chain, respectively, were deleted in the mouse germ- 
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line and a profound deficiency in the development of IgG1 or IgE expressing memory B cells 
was observed (Achatz et al., 1997; Kaisho et al., 1997). These results were complemented and 
supported by a study in which transgenic expression of γ1 or µ/γ hybrid chains conferring a 
particular antigenic specificity in combination with a transgenic κ light chain led to an 
enhanced generation of memory and plasma cell progeny upon antigenic challenge, due to 
reduced cellular attrition (Martin and Goodnow, 2002).  
1.2.2 Igα and Igβ  
The Igα/β heterodimer is expressed on the surface of B cells as part of the BCR 
complex. On the other hand, it is also integral to the pre-BCR. A functional pre-BCR is 
required for pre-B cell expansion and the down-regulation of further HC rearrangement. The 
importance of the Igα/β heterodimer in the pre-BCR is evidenced by the fact that only pro-B 
cells were detectable in mice containing truncations of both Igα and Igβ (Reichlin et al., 
2001). Conversely, in mice containing either a truncated Igα or a truncated Igβ, the B lineage 
cells proceed through this checkpoint, undergo VH to DJH rearrangement and establish a pre-B 
cell population. In mice containing the Igβ truncation and therefore expressing a pre-BCR 
containing only functional Igα, normal numbers of pre-B cells were generated, indicating 
substantial pre-B expansion (Reichlin et al., 2001). In contrast, in mice containing the Igα 
truncation and therefore expressing a pre-BCR containing only Igβ, reduced numbers of pre-B 
cells were observed (Torres et al., 1996). Thus signals downstream of Igα appear more 
efficient at supporting the pro-B to pre-B transition or expanding pre-B cells. 
Pre-B cells undergo rearrangement at the LC locus and those that express a functional 
BCR make the transition to immature B cells. Mice containing the Igβ truncation exhibited 
normal levels of immature B cells (Reichlin et al., 2001). On the contrary, in mice containing 
a truncated Igα, reduced levels of pre-B cells were matched by an equivalent reduction in 
immature B cell numbers (Torres et al., 1996). This suggests the possibility that the transition 
from pre-B to immature B cell is supported either by Igα or Igβ with equal efficiency. 
After productive light chain rearrangement resulting in immature B cells, subsequent 
maturation generated a pool of mature recirculating B cells. The transition from immature to 
mature B cells is strikingly reduced in mice containing either the Igα or Igβ truncation, with 
most immature B cells undergoing programmed cell death (Torres et al., 1996). Consequently, 
while expression of the cytoplasmic domains of either Igα or Igβ is sufficient to support B 
lineage development to the immature B cell stage, albeit with differing efficiencies, the 
cytoplasmic domains of both Igα and Igβ are required for the efficient establishment of a 
mature B cell pool. 
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1.2.3 B Cell Response and B Cell Receptor Signaling 
Antigen recognition by the BCR leads to a multitude of cellular responses in mature B 
cells. These responses include antigen internalization, T cell-independent B cell proliferation, 
and antibody production, as well as antigen presentation and the T cell-dependent antibody 
response. Experiments in cell lines and mice have provided insights into the proximal 
signaling requirements of the events after BCR engagement.  
Aggregation of the BCR results in the phosphorylation of the immunoreceptor tyrosine-
based activation motif (ITAM) tyrosine residues on Igα and Igβ by binding and activating 
spleen tyrosine kinase (Syk) and Lyn tyrosine kinase (Lyn) (Kurosaki, 1999), which are the 
first protein tyrosine kinases to be activated. Lyn stimulates receptor internalization and 
consequently negatively regulates aspects of BCR-dependent signaling (Ma et al., 2001). 
Moreover, Lyn and Syk phosphorylated a specific set of proximal BCR signaling molecules 
such as Bruton’s tyrosine kinase (Btk), phospholipase Cγ2 (PLCγ2) (Fruman et al., 2000), 
which subsequently form a supramolecular complex upon BCR crosslinking, nucleated by the 
tyrosine phosphorylated form of the adaptor B cell linker protein (BLNK) (Chiu et al., 2002; 
Fu et al., 1998; Wienands et al., 1998). This complex, also termed B cell signalosome, 
connects the BCR with pathways implicated in cellular activation and proliferation such as the 
calcium response and the nuclear factor κB (NF-κB) and mitogen-activated protein (MAP) 
kinase pathways (Gugasyan et al., 2000; Ishiai et al., 1999; Kur- osaki, 1999; Tan et al., 
2001).  Less is known about signaling requirements downstream of the BCR for the induction 
of antigen presentation to T cells and the T cell-dependent antibody response, although Syk 
may play a role in this respect (Lankar et al., 1998).  
1.2.4 Aim of the Project 
The conspicuous absence of the cytoplasmic tails in µ and δ chains could reflect 
peculiar signaling requirements in pre-B and immature B cells, predicting that expression of 
IgH chains with cytoplasmic tails would compromise B cell development. Indeed, while δ 
chains alone can perfectly well mediate B cell development (Lutz et al., 1998; Roes and 
Rajewsky, 1991), transgenic expression of γ chains of various classes often seemed to disturb 
normal development (Roth et al., 1995), sometimes promoting the generation of cells co-
expressing endogenous µ and δ chains (Chu et al., 2004). However, the physiological 
significance of these experiments remained uncertain, given the variations in transgene copy 
number and consequently expression levels inherent in the experimental approach. In order to 
investigate the physiological role of γ1 chain containing BCRs, a new mouse model, termed 
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IgG1i, was generated in our laboratory using gene-targeting techniques. In this model the Cγ1 
gene segment in the mouse germ line replaced the Cµ. 
The signaling function of the B cell antigen receptor (BCR) on µ and δ cells is thought 
to rely entirely on the cytoplasmic tails of the BCR-associated Igα/β heterodimer. It remains 
to be answered whether the role of the γ1 chain in keeping B cells compartment is dependent 
on, or independent of, the Igα or Igβ chain. Therefore, mice homozygous for the Igα 
truncation mutation and homo- or heterozygous for IgG1i (IgαΔcIgG1i or IgαΔcIgG1i/+) or 
homozygous for the Igβ truncation mutation and homo- or heterozygous for IgG1i 
(IgβΔcIgG1i or IgβΔcIgG1i/+) were generated. We also generated the triple mutant mice that 
are homozygous for the Igα truncation mutation and homozygous for the Igβ truncation 
mutation as well as γ1 insertion (IgαΔcIgβΔcIgG1i). In those mouse models, we dissected the 
interaction among the IgG1, Igα and Igβ in each B cell developmental stage and evaluated B 
cell survival, proliferation and activation.  
1.3 Smad7 
While responding to pathogens the immune system maintains tolerance to self and 
harmless antigens. Multiple mechanisms operate to ensure this normal immunological 
function. Of those, transforming growth factor-β (TGF-β) is a potent regulatory cytokine with 
diverse effects on haematopoietic cells. The pivotal function of TGF-β in the immune system 
is to maintain tolerance via the regulation of lymphocyte proliferation, differentiation, and 
survival (Li et al., 2006a).  
TGF-β receptor complex consists of TGFβRI (ALK5) and TGFβRII (Fig.4). Active 
TGF-β dimmer binds to the tetrameric ALK5 and TGFβRII receptor complex to initiate cell 
signaling. Activated ALK5 phosphorylates receptor-activated Smads (R-Smads), Smad2 and 
Smad3, which translocate into the nucleus in a complex with Smad4. The Smad complex 
binds to a target promoter in association with other transcription factors (TFs) and regulates 
gene expression via recruiting histone acetyltransferase (HAT) or histone deacetylase 
(HDAC). The regulatory activity of TGF-β is modulated by the presence of inflammatory 
cytokines and costimulatory molecules and by the intracellular inhibitory Smad proteins (I-
Smads) that include Smad6 and Smad7. 
1.3.1 Smad7 Works as an Inhibitor of TGF-β  Signaling 
Smad7 regulates signaling of TGF-β in several ways (Fig.2). It is originally shown to 
compete with R-Smads for binding to activated type I receptors and thus to inhibit the 
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phosphorylation of R-Smads. Subsequently, they were found to recruit E3-ubiquitin ligases, 
known as Smad ubiquitination regulatory factor 1 (Smurf1) and Smurf2, to the activated type 
I receptor, resulting in receptor ubiquitination, degradation and termination of signaling. 
Smad7 was also shown to recruit a complex of GADD34 (Growth Arrest and DNA Damage-
Inducible Protein) and the catalytic subunit of protein phosphatase 1 to the activated TGF-β 
type I receptor, resulting in receptor dephosphorylation and inactivation and termination of 
signaling.  
        
Fig. 2 Smad7-dependent inhibition 
Smad7 down-regulates TGF-β  signaling (A) by competing with Smad2 and Smad3 for ALK5 binding and (B) by 
degrading ALK5 through recruiting Smurf-containing E3 ubiquitin ligase complexes (Li et al., 2006a). 
1.3.2 TGF-β-associated Diseases by Aberrant Expressions of Smad7 
An excessive or deficient expression of Smad7 disrupts the balanced activity of TGF-β. 
Abnormal expression of Smad7 is hypothesized to be one of the causes behind TGF-β-
associated diseases (Park, 2005). Blocking TGF-β signaling by over-expression of Smad7 
helps to maintain the chronic production of pro-inflammatory cytokines that drive the 
inflammatory process in IBD, and inhibition of Smad7 enables endogenous TGF-β to down 
regulate this response (Monteleone et al., 2001). On the other hand, the deficient Smad7 
expression plays a key role in hyperresponsiveness to TGF-β in fibroblasts and development 
of the sclerotic skin diseases. The deficiency of Smad7 is presumably due to transcriptional 
inhibition of Smad7 gene or excessive degradation of Smad7 protein (Dong et al., 2002). 
Aberrant expression of Smad7 is also observed in certain cancers. Recent study 
demonstrates that Smad7 plays an important role in the development of gastric carcinoma and 
that over-expression of Smad7 may be a significant independent prognostic indicator for 
clinical outcome in patients with gastric carcinoma (Kim et al., 2004). Smad7 overexpression 
is associated with poor outcome in gastric carcinomas, indicating that Smad7 expression may 
present one of the novel mechanisms for TGF-β resistance in human gastric carcinoma. 
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Increased expression of Smad6 and Smad7 has been described in human pancreatic cancers 
(Kleeff et al., 1999;), but the mechanisms underlying these changes in Smad7 expression still 
remains unresolved.  
1.3.3 TGF-β  and B Lymphocytes 
It is known that TGF-β induces apoptosis in immature B cells and resting B cells (Lomo 
et al., 1995). TGF-β gives rise to NF-κB inhibitor IkBα and inhibits NF-κB activation 
(Arsura et al., 1996), which could lead to up-regulation of the BH3-only protein Bim, a 
proapoptotic member of the Bcl-2 family (Wildey et al., 2003). TGF-β can also mediate 
apoptosis by down-regulating c-myc and inducing the expression of Id3 (inhibitor of DNA 
binding 3) (Kee et al., 2001). Interestingly, both c-myc and Id3 regulate B cell proliferation. 
Therefore, the anti-proliferation pathway and the apoptotic pathway of TGF-β may overlap 
significantly. This is evidenced by the fact that TGF-β induced apoptosis is associated with 
cell cycle blockade at G1/S because TGF-β represses cyclin A expression and inactivates 
cyclin-dependent kinase 2 (cdk2), possibly via the up-regulation of the cyclin-dependent 
kinase inhibitor p27. 
Other signaling pathways such as CD40 also modulate TGF-β regulation of B cell 
proliferation. Engagement of CD40 can induce Smad7 expression and protects B cells from 
TGF-β-induced growth inhibition (Patil et al., 2000).  
TGF-β promotes switching to IgA and IgG2b in mouse B cells in vitro (Kim and 
Kagnoff, 1990; McIntyre et al., 1993). In contrast, mice with a blockade of TGF-β signaling 
in B cells showed that TGF-β signaling is dispensable for IgG2b production. In these mice, 
serum IgA was absent whereas inactivation of TGF-β signaling in B cells results in elevation 
of other serum Ig isotypes (Cazac and Roes, 2000). These in vivo studies reveal a general 
inhibitory function for TGF-β on antibody production with the exception of IgA (Fig.3). 
          
Fig. 3 TGF-β  regulation of B cell responses.  
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TGF-β inhibits B cell proliferation through induction of Id3, p27, and p21 and inhibition of c-myc. TGF-β  
promotes class switching to IgA through Smad3/4 and CBFα3-mediated transactivation of germline α-promoter. 
TGF-β also induces apoptosis in immature and resting B cells through induction of Id3 and Bim, and inhibition 
of NF-κB and c-myc (Li et al., 2006a). 
1.3.4 Aim of the Project 
TGF-β signaling is involved in the proliferation, differentiation, and survival of B-
lymphocytes. In the mouse model, the absence of TGF-βRII in B cells leads to a reduced life 
span of conventional B cells, expansion of peritoneal B-1 cells, and B cell hyperplasia in 
Peyer's patches, elevated serum immunoglobulin, and a virtually complete serum IgA 
deficiency. Therefore, it is interesting to evaluate the physiological role of Smad7, the TGF-
β signal inhibitor, in B cells proliferation, class switch, and survival and figure out the 
Smad7-regulated signaling pathway of TGF-β receptor in the B cells. To disrupt the Smad7 
selectively in B cells, Smad7flox mice were crossed to CD19-Cre mice, which induce 
efficient B lineage-specific deletion of LoxP-flanked target sequences. Using these mice, we 
analyzed the role of Smad7 in B cell activation and homeostasis. 
1.4 NF-кB inducing kinase (NIK) 
1.4.1 The NF-кB Family Members and Their Regulation 
In mammals, NF-кB is composed of homo- or heterodimers of five proteins belonging 
to the Rel family, which are RelA, RelB, c-Rel and NF-кB1 (p105/p50) as well as NF-кB2 
(p100/p52). (Li and Verma, 2002, Ghosh et al., 1998) These Rel proteins form different NF-
кB homo- and heterodimers, whose activation depends on two major NF-кB activation 
pathways: the canonical and the non-canonical pathway. 
The canonical NF-кB activation pathway is the predominant pathway occurring in most 
cells. Dimer combinations of RelA, c-Rel and p50, which are kept inactive in the cytoplasm 
by their specific inhibitors, the IкB proteins (Ghosh and Karin, 2002), are activated by the 
canonical pathway. This pathway is essential for immune responses, inflammation and 
promoting cell survival.  
The non-canonical pathway affects NF-кB2/p100, which preferentially dimerizes with 
RelB in the cytoplasm (Solan et al., 2002). This pathway is triggered by certain members of 
the tumor necrosis factor (TNF) cytokine family (Senftleben et al., 2001). Stimulation of a 
subset of receptors belonging to the TNFR super-family (such as BAFF-R, CD40, RANK, 
LTαR and LTßR) leads to the recruitment of TRAF proteins like TRAF2, TRAF3 and 
TRAF6. This activates the NF-кB inducing kinase (NIK) through a currently unknown 
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mechanism. NIK then selectively phosphorylates and activates the IKKα catalytic subunit. 
Activated IKKα homodimers in turn phosphorylates the NF-кB precursor p100. p100 is 
subsequently polyubiquitinated and then processed to the mature subunit p52 by the 
proteasome (Massoumi et al., 2006). p52 and its binding partner RelB then enter the nucleus 
to turn on the transcription of target genes (Sun and Chen, 2004)(Fig.4). 
This pathway is important for secondary lymphoid organogenesis, maturation of B cells, 
adaptive humoral immunity and optimal promotion of cell survival (Zarnegar et al., 2004). 
 
 
 
 
 
Fig. 4: Schematic overview of the Non-Canonical 
Pathway of NF-кB activation 
Proteins are depicted by name and by oval symbols. 
Receptors are symbolized by boxed names. Arrows 
indicate activation processes. P stands for phospho-
groups, and Ub for ubiquitin. 
   
1.4.2 NIK Deficient Model 
Alymphoplasia (aly) mice, which carry a spontaneous point mutation in the NIK gene, 
are characterized by the systemic absence of lymph nodes and Peyer’s patches, disorganized 
splenic and thymic architectures, and immunodeficiency (Miyawaki et al., 1994). Another 
unique feature of aly/aly mice is that they exhibit increased numbers of B1 B cells in the 
peritoneal cavity compared to aly/+ mice. Transfer experiments of peritoneal lymphocytes 
from aly/aly mice into RAG-2 mice revealed that B and T cells fail to migrate to lymphoid 
tissues, particularly to the gut-associated lymphatic tissue system (Fagarasan et al., 2000). The 
migration defect of aly/aly lymphocytes was due to impaired signal transduction downstream 
of the receptors, indicating that NIK is involved in the chemokine-signaling pathway.  
NIK knockout mice (NIK–/–) displayed similar abnormalities in both lymphoid tissue 
development and antibody responses that observed in aly mice (Yin et al., 2001). In addition, 
a phenotype of immuno-suppression mediated by CD25–Foxp3– memory CD4+ cells were 
observed in the mice deficient for NIK (Ishimaru et al., 2006). Biochemical studies of those 
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cells indicated an involvement of a cell-intrinsic mechanism in which NF-κB2 (p100) limits 
nuclear translocation of NF-κB1–RelA and thereby functions as a regulatory ‘brake’ for the 
activation of naive T cells. Moreover, analyses of NIK–/– mice showed that although NIK is 
essential for B and T cell activation, it is dispensable for activation of dendritic cells (DCs) 
(Garceau et al., 2000). 
1.4.3 Aim of the Project 
Deficiency of NIK (aly/aly) causes defects in the formation of secondary lymphoid 
organs in embryonic development in mice (Miyawaki et al., 1994) but the role of NIK in 
postnatal maturation of lymph nodes and Peyer’s patches remains unclear. Further, NIK 
knockout mice exhibit various phenotypes in different lineages. Due to the complex 
interaction between lineages such as B and T cells, the importance of NIK in cellular lineage 
and development stage are not known. To identify the physiological functions of NIK, we 
disrupted the NIK locus using conditional gene targeting, an established genetic method to 
investigate the gene function solely in the specific tissues and/or cell types. 
1.5 BAC Strategy for Gene Targeting 
1.5.1  BAC (bacterial artificial chromosome) 
BACs can be used to clone DNA fragments of up to 300kb. The vectors are based on the 
naturally occurring large E. coli plasmid called the F-factor. This plasmid contains two genes, 
parA and parB, which maintain the copy number of the F-factor at 1-2 per cell. Recombinant 
BACs containing large DNA fragments are produced as in standard plasmid vector cloning. 
BACs are introduced into E. coli cells by electroporation. Large DNA fragments cloned into 
BACs have been found to be stable through hundreds of generations (Shizuya et al., 1992). 
Recently, huge BAC libraries have been generated and were used for shotgun sequencing of 
several genomes. BAC stocks are available from the Children’s Hospital of Oakland Research 
Institute (CHORI). 
1.5.2 RED/ET Cloning 
All targeting techniques described so far require the production of complicated targeting 
constructs. This is often a limitation, since the availability of unique restriction sites on 
targeting vectors and genomic DNA is restricted and also the capacity with respect to insert 
size of the usual cloning vectors is limited. Development of efficient phage-based 
homologous recombination systems in the past five years has made it possible to engineer 
large segments of genomic DNA very easily (Murphy, 1998; Zhang et al., 1998, Yu et al. 
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2000, Muyrers et al, 1999). With this new technique it is possible to engineer bacterial 
artificial chromosomes (BACs) in a way that they can be used as targeting vectors later on.  
Red/ET recombination relies on homologous recombination in vivo in E.coli. It allows a 
wide range of modifications of DNA molecules at any chosen position. Homologous 
recombination allows the exchange of genetic information between two DNA molecules in a 
precise, specific and faithful manner (Copeland et al., 2001; Liu et al., 2003). These qualities 
are optimal for engineering a DNA molecule regardless of its size. Therefore Red/ET cloning 
is a valuable tool to generate targeting vectors with very long stretches of homology to the 
target gene. (Fig.5) 
 
Fig.5 Applications of Red/ET  (genebridges) 
Red/ET allows every type of DNA engineering possible regardless of target size or type of modification. 
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2 MATERIALS AND METHODS 
 
2.1 Chemicals and Biological Material 
Chemicals were purchased from Sigma-Aldrich (Steinheim), Fluka Chemie 
(Deisenhofen), Merck (Darmstadt) or AppliChem (Darmstadt) unless stated otherwise. 
Solutions were prepared with double distilled water (ddH2O). Bacterial media were 
autoclaved prior to use. 
Sterility of solutions and chemicals used in cell culture was maintained by working 
under a sterile hood (Heraeus, Germany). 
 
 
Name of chemical Supplier 
β-Mercaptoethanol (β-ME) Fluka Chemie GmbH, Switzerland 
Acetone Merck, Darmstadt 
Agar Gibco Life Technologies GmbH, Karlsruhe 
Agarose, electrophoresis grade AppliChem, Darmstadt 
Ampicillin Sigma-Aldrich, Steinheim 
L-Arabinose Sigma-Aldrich, Steinheim 
Bovine serum albumin (BSA) Sigma-Aldrich, Steinheim 
Calcium chloride Sigma-Aldrich, Steinheim 
Chloroform Merck, Darmstadt 
Citric acid Fluka Chemie GmbH, Switzerland 
2’-Deoxyguanosine Monohydrate AppliChem, Darmstadt 
Diethylpyrocarbonate (DEPC) AppliChem, Darmstadt 
Dextran sulfate AppliChem, Darmstadt 
Dextrose Merck, Darmstadt 
Dithiothreitol (DTT) Boehringer Mannheim GmbH, Mannheim 
Dimethylsulfoxide (DMSO) Merck, Darmstadt 
Materials and Methods 
 
 
24 
dNTPs Pharmacia Biotech, USA 
Ethylendiamine tetraacetate (EDTA) Fluka Chemie GmbH, Switzerland 
Ethanol, abs. AppliChem, Darmstadt 
Ethidium bromide Sigma-Aldrich, Steinheim 
Fetal calf serum (FCS) Boehringer Mannheim GmbH, Mannheim 
Ficoll 400 Amersham Pharmacia, Freiburg 
Glacial acetic acid Fluka Chemie GmbH, Switzerland 
Hydrochloric acid (37 %) Merck, Darmstadt 
Isopropanol AppliChem, Darmstadt 
Magnesium chloride Sigma-Aldrich, Steinheim 
Magnesium chloride (for PCR) Gibco Life Technologies GmbH, Karlsruhe 
Mineral oil Sigma-Aldrich, Steinheim 
Orange G Chroma Gesellschaft Schmidt & Co, Stuttgart 
Phenol Sigma-Aldrich, Steinheim 
Potassium acetate Fluka Chemie GmbH, Switzerland 
Potassium chloride Merck, Darmstadt 
Proteinase K Roche, Switzerland 
Salmon sperm DNA Biomol, Hamburg 
Sodium azide Fluka Chemie GmbH, Switzerland 
Sodium chloride AppliChem, Darmstadt 
Sodium citrate Fluka Chemie GmbH, Switzerland 
Sodium dodecyl sulfate AppliChem, Darmstadt 
Sodium hydrogencarbonate Fluka Chemie GmbH, Switzerland 
Sodium hydroxide Fluka Chemie GmbH, Switzerland 
Tris base Fluka Chemie GmbH, Switzerland 
Tris/ HCl AppliChem, Darmstadt 
Table 1: Chemicals  
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2.2 Molecular biology 
Standard methods of molecular biology were performed – if not otherwise stated- 
according to protocols described in Sambrook et al. (1989). 
2.2.1 Competent Cells and Isolation of Plasmid DNA 
Competent Escherichia coli DH5α or M1 or Topo 10 cells were prepared according to 
the protocol of Inoue et al. (Inoue et al., 1990) and used in heat shock transformations of 
plasmid DNA. DNA ligation was performed with the NEB DNA ligase according to the 
manufacturer’s instructions. Plasmid DNA was isolated from transformed Escherichia coli 
bacteria with an alkaline lysis method (QIAGEN, Hilden, Germany). The procedure was 
performed according to the protocol of (Zhou et al., 1990). Mini or Maxi Plasmid DNA of 
higher purity was obtained with QIAGEN columns (QIAGEN, Hilden, Germany) following 
the supplier’s instruction. 
2.2.2 Preparation of BAC DNA 
Preparation of BAC DNA is very similar to preparation of plasmid DNA. Some 
precautions must be taken in order to maintain the integrity of the BAC. Vortexing or shaking 
should be left out, because this may lead to shearing of the BAC. 
2.2.2.1 Mini Preparation of BAC DNA 
BAC DNA was prepared from a 5 ml overnight culture. Four ml of this culture were 
used for every lysis. Cells were centrifuged at 13000 rpm for 3 min. The pellet was dissolved 
in 200 µl of buffer P1. 220 µl P2 were added followed by gentle shaking of the tubes. The 
solution was incubated for a maximum of 5 min at room temperature. Subsequently, 220 µl of 
P3 were added. After 5 min incubation the solution was centrifuged for 10 min at 13000 rpm, 
the cleared supernatant was transferred into a fresh 1.5 ml tube. BAC DNA was precipitated 
with 550 µl of isopropanol and washed with 70 % (v/v) ethanol. The DNA pellet was directly 
resuspended in a restriction digest mix to avoid any shearing of the BAC DNA. 
2.2.2.2 Maxi Preparation of BAC DNA 
BAC DNA was prepared from a 200 ml overnight grown culture. Cells were pelleted at 
4700 rpm for 15 min. DNA extraction was performed using the Nucleobond AX 500 kit 
(Macherey + Nagel, Düren) following the manufacturer’s instruction. After clearance of 
genomic DNA and cell debris by centrifugation, the protocol was modified. The cleared lysate 
was filtered through a sterile nylon mesh. Afterwards the DNA was precipitated with an equal 
Materials and Methods 
 
 
26 
amount of isopropanol (centrifugation: 4700 rpm, 25 min, 4°C). The DNA was washed twice 
with 5 ml of 70 % (v/v) ethanol (centrifugation: 4700 rpm, 10 min, room temperature) and 
resuspended in 200 µl of TE buffer. Prior to use in transfection of ES cells, the DNA was 
purified following the phenol/chloroform extraction protocol. To prevent shearing of the 
DNA, the solution was not vortexed, but gently shaken. 
2.2.3 Preparation of Genomic DNA 
Genomic DNA was prepared using a simplified protocol that allows the turnover of 
many samples at the same time (Laird et al., 1991). DNA from either mouse-tail biopsies or 
ES cells was extracted. 
2.2.3.1 DNA Extraction from Mouse Tail Biopsies 
Cells were lysed over night at 56°C in lysis buffer (10 mM Tris-HCl, pH 8; 10 mM 
EDTA; 150 mM NaCl; 0.2% (w/v) SDS; 400 mg/ml proteinase K). Subsequently, DNA was 
precipitated from the solution by the addition of an equal volume of isopropanol. DNA was 
pelleted by centrifugation, washed in 70% (v/v) EtOH and resuspended in TE-buffer (10 mM 
Tris-HCl, pH 8; 1 mM EDTA). 
2.2.3.2 DNA Extraction from ES Cells (96-well micro titer plates) 
After washing ES cells twice with 100 µl PBS, 50 µl of ES cell lysis buffer was added 
to each well. The plates were transferred into a pre-warmed humidified box in which 
digestion of cellular proteins proceeded overnight at 56°C. After lysis and denaturation, 
samples were cooled to room temperature for 1 h. ES cell derived genomic DNA was 
precipitated with absolute ethanol for an additional hour at room temperature. DNA strands 
were visible under the microscope. To remove the ethanol the plates were inverted and the 
wells carefully drained on paper towels. DNA usually remained attached to the plastic 
surface. Every well was washed three times with 70 % (v/v) ethanol. DNA was air-dried and 
ready for further processing, e.g. restriction digests. 
 
ES cell lysis buffer 
10 mM Tri/HCl pH 7.5 
10 mM EDTA 
0.5 % (w/v) sarcosyl (sodium lauryl sarcosinate) 
10 mM NaCl 
0.4 mg/ml proteinase K (added prior to lysis) 
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2.2.4 Preparation of RNA 
2.2.4.1 RNA Extraction by using TRIzol Reagent 
Cells were washed off the culture plate inserts with 500 µl of PBS. Cells were collected 
by centrifugation (3500 rpm, 5 min) and resuspended in 1 ml of TRIzol Reagent (GibcoBRL, 
USA). RNA was either prepared directly afterwards or the cells were stored at -80°C for 
storage. All the following steps were performed at a separate workbench, using filtered tips, a 
separate set of pipettes, and keeping the tubes on ice at all times. The TRIzol Reagent, a 
monophasic solution of phenol and guanidine isothiocyanate, is an improvement of the single-
step RNA isolation method developed by Chomczynski and Sacchi (Chomczynski, P., and 
Sacchi, N. 1987). Cells were lysed by pipetting up and down several times. The homogenized 
cells were incubated at room temperature for 5 min to allow the complete dissociation of 
nucleoprotein complexes. Chloroform (0.2 ml) was added to each tube and the tubes were 
shaken vigorously for 15 sec and then incubated for 3 min at room temperature. Tubes were 
centrifuged at 13000 rpm for 15 min at 4°C. The mixture separates into an upper aqueous 
phase containing the RNA, an interphase with proteins, and a lower phenol-chloroform phase. 
The upper phase was transferred into a fresh tube and the RNA was precipitated with 0.5 ml 
isopropanol. The samples were incubated for 10 min at room temperature and the RNA was 
collected by centrifugation (13000 rpm, 10 min, 4°C). The supernatant was removed carefully 
and the RNA was washed with 1 ml 70 % (v/v) ethanol prepared with DEPC treated water 
(6000 rpm, 5 min, 4°C). Diethylpyrocarbonate (DEPC; AppliChem, Darmstadt) inactivates 
RNases. The ethanol was completely removed and the RNA was dried for a maximum of 10 
min at room temperature. Afterwards the RNA was dissolved in 30 µl of DEPC-water for 10 
min at 55°C. It was stored at -20°C for later preparation of cDNA. 
2.2.5 cDNA Synthesis 
8 µl of total RNA were mixed with 2 µl of 10 mM dNTP mix, 2 µl of oligo (dT12-18) (0.5 
µg/µl) and 18 µl of DEPC treated water. The mixture was incubated at 65°C for 5 min. After 
a 2 min incubation on ice, 4 µl of 10 x RT buffer, 8 µl of 25 mM MgCl2, and 4 µl of 0.1 M 
DTT were added and incubated for 2 min at 42°C. At this point, 1 µl of Superscript II reverse 
transcriptase was added. All reagents were purchased from Invitrogen, USA. cDNA synthesis 
was performed at 42°C for 50 min. The reverse transcriptase was inactivated at 70°C for 15 
min. The cDNA was stored at -20°C for further analysis. 
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2.2.6 Agarose Gel Electrophoresis and DNA Gel Extraction 
Separation of DNA fragments by size was achieved by electrophoresis in agarose gels 
(0.8% - 2% (w/v); 1x TAE (Sambrook, 1989); 0.5 mg/ml ethidium bromide). DNA fragments 
were recovered from agarose gel slices with either the QIAEX II or the QIAquick Gel 
Extraction Kit (QIAGEN, Hilden, Germany) following the manufacturer’s instructions. 
2.2.7 DNA Sequencing 
DNA was sequenced using the 'Big Dye termination Cycle Sequencing Kit' (Applied 
Biosystems, Foster City, USA), which is a PCR-based modification of the original Sanger 
protocol (Sanger et al., 1977). The fluorescently labeled DNA fragments were separated and 
analysed with the ABI373A and ABI377 systems (Applied Biosystems, Foster City, USA). 
2.2.8 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction is a rapid procedure for in vitro enzymatic amplification 
of a specific segment of DNA (Saiki et al., 1985; Saiki et al., 1988). The first step of PCR 
simply entails mixing template DNA, two appropriate oligonucleotide primers (18-75 
nucleotides), Taq or another thermostabile polymerases, deoxyribonucleoside triphosphates 
(dNTPs), and a buffer. Once assembled, the mixture is cycled many times (usually 25-40) 
through temperatures that permit denaturation (94-95°C), annealing (54-61°C) and DNA 
synthesis (68-72°C) to exponentially amplify a product of specific size and sequence (Mullis 
et al., 1986; Mullis, 1990). The Taq polymerase synthesizes the complementary strand 
starting from the 3’ end of the primer. PCR reactions were performed with the PTC-200 PCR 
cycler (MJ Research) or Biometra Trio Thermoblock (Biometra). 
To amplify cDNA fragments for cloning or sequencing, the High Fidelity Master Kit 
with proofreading activity was used. (Roche, Mannheim, Germany) 
2.2.9 Southern Blot 
Southern blotting is the transfer of DNA fragments from an electrophoresis gel to a 
membrane. The transfer results in immobilization of the DNA fragments, so the membrane 
carries a semi-permanent reproduction of the banding pattern of the gel. After immobilization, 
the DNA can be hybridized with radioactively labeled probes and visualized by 
autoradiography (Southern, 1975). 
Genomic DNA was digested with restriction endonucleases, and the resulting fragments 
were separated according to size by agarose gel electrophoresis on a 0.7 % (w/v) agarose gel. 
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The DNA was denatured in situ and transferred onto a positively charged nylon membrane. 
Blotted DNA was fixed by incubation at 80°C for 20 min. The DNA was hybridized to a 32P-
radioactively labeled DNA probe specific for the desired genomic region. Autoradiography 
was used to locate the positions of bands to which the probe hybridized. 
2.2.9.1 Preparation and Transfer of the DNA Samples 
Southern blot analysis was used to identify the targeted allele in the genome of ES cells, 
for typing of genetically modified mice and to identify targeted BACs. 
The digested DNA and a DNA size marker were separated on a 0.7 % agarose gel 
overnight (40V, 16 h). The gel was photographed under UV light with a ruler aligned to the 1 
kb DNA size marker and its bands were marked with a yellow tip. Afterwards the gel was 
gently shaken in 0.25 M HCl for 15-20 min that leads to partial depurination of the DNA, 
which in turn leads to strand cleavage. The HCl was exchanged with a 0.4 M NaOH solution 
which functions as a denaturation agent, to obtain single-stranded DNA. The DNA is ready to 
be transferred onto a positively charged nylon membrane (Hybond N+, Amersham 
Biosciences, UK). The DNA was transferred using downward capillary transfer with an 
alkaline transfer buffer. Transfer was performed for 4-16 h.  
After completion of the transfer, the membrane was marked with a pencil corresponding to 
the previously marked size marker. Afterwards the membrane was baked for 20 min at 80°C 
to immobilize the DNA on the membrane. 
 
Depurination buffer  Denaturation buffer  Transfer buffer 
0.25 M HCl   0.4 M NaOH   0.4 M NaOH 
        0.6 M NaCl 
2.2.9.2 Hybridization 
After baking of the membrane, it was moistenend with 2 x SSC and thereafter incubated 
in a rotating oven for at least 2 h at 65°C with prehybridization solution. In the meantime, the 
DNA probe was labeled with 32P. 
30-100 ng of DNA (probe) were mixed with 2 µl of random primers (TaKaRa labeling 
kit) and filled up with water to a final volume of 10 µl. The solution was boiled for 5 min, to 
get single stranded DNA. After 5 min incubation on ice, 2.5 µl of Bca buffer, 2.5 µl of 
dNTPs, 6.5 µl of H2O, 1.0 µl of Bca BEST polymerase (all components part of the TaKaRa 
labeling kit) and 25 µCi 32P-CTP were added. The mix was incubated at 55°C for 1 h. The 
labeling reaction was stopped by adding 100 µl of H2O. The labelled probe was purified from 
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non-incorporated nucleotides on a Micro Spin S 200 HR column (Amersham Bioscience, 
UK). The purified probe was boiled for 5 min, incubated on ice for 3 min and finally added to 
the prehybridization solution. Hybridization was performed by rotating the membrane in the 
solution overnight at 65°C. To avoid background labeling, the membrane was washed the 
next day with 2 x SSC/ 0.1 % SDS and 1 x SSC/ 0.1 % SDS until the counts decreased to 40-
100 cpm. Afterwards, the membrane was sealed in a plastic bag. The blot was analyzed by 
phosphoimaging. The sizes of the bands were estimated using their electrophoretic mobility 
relative to the previously photographed gel or per overlay with the marked bands of the size 
ladder on the blot. 
Prehybridization solution    20 x SSC 
1 M NaCl      3 M NaCl 
50 mM Tris pH 7.5     300 mM sodium citrate 
10 % (w/v) dextrane sulfate    adjust to pH 7.0 w/ NaOH 
1 % (w/v) SDS 
250 µg/ml salmon sperm DNA (sonicated) 
2.2.10 Red/ET Cloning 
The Plasmid pSC101-BAD-gbaA-tetra (available from GeneBridges, Dresden) carries 
the λ phage redγβα operon expressed under the control of the arabinose-inducible pBAD 
promoter (Guzman et al. 1995) and confers tetracycline resistance. The pBAD promoter is 
both positively and negatively regulated by the product of the araC gene (Schleif, 1992). 
AraC is a transcriptional regulator that forms a complex with L-arabinose. Arabinose binds to 
AraC and allows transcription to begin. In the absence of arabinose transcription is blocked by 
the AraC dimer. To minimize toxic side effects of the red γ gene, expression is tightly 
controlled. The plasmid is a derivative of a thermo sensitive pSC101 replicon which is a low 
copy number plasmid depending on the oriR101. The RepA protein encoded by plasmid 
pSC101 is required for plasmid DNA replication and the partitioning of plasmids to daughter 
cells at division (Miller et al., 1995). Since a temperature sensitive (Ts) RepA protein is 
expressed cells have to be cultured at 30°C, pSC101 derivatives are easily curable at 37°C to 
43°C. The temperature-sensitivity of the RepA proteins leads to a rapid loss of the plasmid in 
the absence of continued selection pressure. 
We used the system of GeneBridges, Dresden. 
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2.2.10.1 Transformation of pSC101-BAD-gbaA into the E. coli Strain Carrying the BAC 
Ten colonies carrying the BAC were picked and inoculated in an Eppendorf tube 
containing 1.0 ml LB medium supplemented with 15 µg/ml chloramphenicol. The lid was 
punctured for ventilation. The tubes were cultured overnight at 37°C shaking at 300 rpm. The 
next day, a fresh Eppendorf tube containing 1.4 ml LB medium conditioned with 
chloramphenicol was inoculated with 30 µl of the overnight culture. Cells were cultured for 
three hours at 37°C shaking at 1000 rpm. All the following steps were performed on ice in a 
cold room. The cells were centrifuged (11000 rpm, 30 sec, 4°C). The pellet was placed on ice 
and resuspended in 1 ml ice-cold dH2O. After centrifugation, cells were resuspended and 
centrifuged a second time. The supernatant was removed leaving 20 to 30 µl in the tube. One 
µl of pSC101-BAD-gbaA were added to the cell slurry. The mixture was transferred into a 
chilled electroporation tube (BioRad, 1 mm). Electroporation was performed at 1800 V, 25 
µF, 200 Ω with the Eppendorf Electroporator 2510. The electroporated cells were 
resuspended in 1 ml LB medium and incubated at 30°C for 60-80 min shaking at 1000 rpm. 
100 µl of those cells were plated on LB agar plates containing tetracycline (3 µg/ml) and 
chloramphenicol (15 µg/ml). The plates were incubated at room temperature for at least 24 h. 
2.2.10.2 Cloning of a PCR Product with Homology Arms into a BAC by Red/ET 
At least ten colonies from the previous transformation were picked and inoculated 
together in a ventilated tube containing LB medium conditioned with tetracycline and 
chloramphenicol. Tubes were incubated at 30°C shaking overnight at 300 rpm. The next day, 
two new tubes containing 1.4 ml fresh medium were inoculated with 30 µl of overnight 
culture. The tubes were incubated shaking at 30°C at 1100 rpm for 2 hours (OD600 ~ 0.2). 20 
µl of 10 % (w/v) L-arabinose were added to one of the tubes to induce the expression of the 
Red/ET recombination proteins. Cells were incubated at 37°C shaking at 1100 rpm for 40 min 
(cells should not grow further than OD600 ~ 0.4). The following steps were performed as 
described above in section 1.2.10.1. Instead of the pSC101-BAD-gbaA, 1 µl of the PCR 
product with homology arms was added to the cell slurry. After electroporation, the cells were 
resuspended in 1 ml of LB medium and incubated at 37°C for 70 min. During this period, 
recombination occurs. 100 µl of the cells were plated on LB agar plates conditioned with 15 
µg/ml chloramphenicol and 50 µg/ml kanamycin. The plates were incubated at 37°C 
overnight. Individual clones were analyzed with PCR and Southern blotting as described 
before. 
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2.3 Cell Culture 
Cells were kept in incubators at 37°C in a humidified atmosphere (5 % (v/v) H2O) and a 
constant CO2 concentration of 10 % (v/v). All procedures requiring sterility were carried out 
under a laminar flow sterile hood (Heraeus). Media and solutions were prepared in sterile 
bottles, with sterile glass or plastic pipettes and filter-sterilized if necessary. 
Material and devices were cleaned with either 70 % (v/v) ethanol or Bacillol (Bode 
Chemie, Hamburg) prior to use. Gloves were worn at all times. Glass pipettes were flamed 
additionally to autoclaving prior to use. 
The described techniques are modified according to Torres and Kühn (Torres and Kühn, 
1997). 
2.3.1 Reagents and Media for Cell Culture 
Embryonic feeder cell (EF) medium (also used for CV-1 5B cells) 
500 ml DMEM w/ Glutamax (Gibco/BRL) 
60 ml EF FCS (Gibco/BRL) 
6 ml 100 x sodium pyruvate (Gibco/BRL) 
 
Embryonic stem cell (ES) medium 
500 ml DMEM (Gibco/BRL) 
75 ml ES FCS (Gibco/BRL) 
6 ml 100 x sodium pyruvate (Gibco/BRL) 
6 ml 100 x L-glutamine (Gibco/BRL) 
6 ml 100 x non-essential amino acids (Gibco/BRL) 
0.6 ml Leukemia inhibitory factor (LIF) 
0.6 ml 0.1 M β-mercaptoethanol (Sigma) 
 
PBS (phosphate buffered saline) 
Dulbecco’s phosphate buffered saline w/o calcium and magnesium (PAA laboratories) 
 
1 x trypsin/EDTA 
10 ml 10 x trypsin/EDTA (Gibco/BRL) 
90 ml PBS 
 
Mitomycin C (MMC) 
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2 mg MMC (Sigma) were dissolved in 2 ml EF medium; filter sterilized and diluted 1:100 in 
200 ml EF medium (final concentration: 10 µg/ml). 7 ml aliquots were stored at -20°C. 
 
0.1 % gelatine (w/v) 
10 ml of a 2 % gelatine stock solution (Sigma) were heated to 37°C and diluted 1:20 in 190 
ml of PBS. 
 
Transfection buffer 
RPMI w/o phenol red (Gibco/BRL) 
 
Geneticin (G418 sulfate, Gibco/BRL) 
Five g G418 sulfate were dissolved in 28 ml of PBS for a 600 x stock solution. 1 ml of this 
stock was added to one bottle of ES medium, resulting in a concentration of 300 µg/ml. Since 
the G418 batch used has a relative activity of 71 %, the final effective working concentration 
was reduced to 225µg/ml. 
 
Ganciclovir (Ganc, Hoffmann-La Roche, Switzerland) 
Ganc was purchased as Cymeven i.v. 4.3 mg of Ganc were dissolved in 80 µl of H2O. 10 µl 
of this stock were diluted 1:100 in ES medium, filter sterilized and diluted 1:1000 in ES 
medium, resulting in a final concentration of 2 µM. 
 
2.3.2 Equipment 
2.3.2.1 Dishes and Plastic Ware 
15 cm plates      TPP, Switzerland 
10 cm plates      Greiner Bio-One, Germany 
6 well plates      Becton-Dickinson, USA 
12 well plates      Becton-Dickinson, USA 
24 well plates      Corning Incorporated, USA 
48 well plates      Corning Incorporated, USA 
96 well plates (round and flat bottom)  Costar, USA 
250 ml tissue culture flask    Greiner Bio-One, Germany 
Plastic pipettes (1, 5, 10 and 25 ml)   Corning Incorporated, USA 
Pipette tips Tip-One     Starlab, Finnland 
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Cryogenic vials     Nunc, Denmark 
15 ml polystyrene tubes    Corning Incorporated, USA 
50 ml polystyrene tubes    Greiner Bio-One, Germany  
Medium reservoir 50 ml    Corning Incorporated, USA 
Filter unit 250 ml     Nalgene, USA 
0.22 µm filter      Millipore, Ireland 
2.3.2.2 Devices 
Heraeus HA 2448 sterile hood   Heraeus, Germany 
Heraeus incubator     Heraeus, Germany 
Gene pulser electroporator    Bio Rad, Germany 
Centrifuge      Heraeus, Germany 
Counting chamber     Neubauer, Germany 
 
2.3.3 Maintenance of Cells 
All cell types were monitored on a daily basis with an inverse phase contrast 
microscope. Fibroblast cell lines like the EF cells or the CV-1 5B cells were passaged when 
they reached confluence. ES cells were not grown to full confluence to avoid differentiation 
of the colonies. Prior to passaging the cells were washed with PBS and trysinized with 1 x 
trypsin at 37°C for 3-6 min depending on the cell type. The cell suspension was washed off 
the plate, transferred into a conical tube and centrifuged at 1200 rpm for 5 min at 4°C. After 
removing the supernatant, the cells were resuspended in their respective medium and plated 
on fresh plates.  
2.3.4 Freezing and Thawing of Cells 
Filter sterilized freezing medium (70 % medium, 20 % FCS, 10 % DMSO) was added to 
trypsinized cells which were then aliquoted into cryogenic vials on ice and slowly frozen at    
-80°C. 24-72 hrs later the cryotubes were transferred into the liqiud nitrogen tank for long 
term storage (Ure et al., 1992). Cells can also be frozen in plates, e.g. 96 well plates. Single 
cell suspensions were mixed with freezing medium to a final DMSO-concentration of 10 %. 
The plates were slowly frozen at -80°C. 
Frozen cells were defrosted in a water bath at 37°C and rapidly transferred into 10 ml of 
medium. The cell suspension was centrifuged at 1200 rpm for 5 min. The supernatant was 
discarded. cells were resuspended in their respective medium and plated on the appropriate 
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amount of plates. Frozen plates were placed on saran wrap and gently shaken in a water bath 
at 37°C. The cell suspension was transferred into a new well and fresh medium was added 
until the well was completely full to compensate for the toxic effects of DMSO. 
2.3.5 Determination of Cell Numbers 
Cell numbers were determined using Neubauer counting chambers. 10 µl of cell 
suspension was pipetted under the coverslip of a counting chamber. Four of the nine big 
quadrants were counted. One big quadrant has a total volume of 0.1 µl. The average cell 
number per quadrant was multiplied by 104 giving the amount of cells present in 1 ml of 
suspension. Total cell numbers were calculated by including the dilution factor and the total 
volume. 
To distinguish between viable and non-viable cells, trypan blue was mixed 1:1 with the 
cell suspension. Trypan blue enters dead cells through the punctured membrane and stains the 
cell blue. Only viable cells were counted. 
2.3.6 Murine Embryonic Feeder Cells 
ES cells have to be kept under conditions that prevent differentiation. For that reason, 
ES cell culture was carried out on mitotically inactivated embryonic feeder cells in ES cell 
medium supplemented with LIF (leukemia inhibitory factor).  
2.3.6.1 Embryonic Feeder Cell Preparation 
For ES cell transfection experiments neomycin resistant embryonic feeder cells are 
required. A male mouse from the transgenic mouse line IL-4 which carries a neomycin 
resistance gene (pEP. IL4:neo, Müller et al., 1991) was crossed to a female C57BL/6 mouse. 
The day after, female mice were checked for a vaginal plug. Plug positive mice were 
sacrificed 13 days later. Embryos were isolated from the opened uterus under sterile 
conditions. After washing them with PBS, embryonic liver, heart and head were removed and 
the remaining material transferred to a PBS containing petri dish. The tissue was digested 
with 50 ml 1 x Trypsin/EDTA for 30 min at 37°C. Afterwards, EF medium was added and the 
cells were collected by centrifugation. The resuspended cells were counted and 2.5x106 cells 
were plated on a 15 cm tissue culture plate. Cells were grown until they reached confluency 
and frozen in aliquots of approximately 5x106 cells according to the procedure described 
previously. 
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For ES cell culture three generations of feeder cells were used. According to their 
passage stage they are called EF1, EF2 and EF3. Freshly isolated EF cells are designated EF0 
cells. For targeting experiments only EF1 or EF2 were used.  
2.3.6.2 Mitomycin C Treatment 
In order to use EF cells to support ES cell growth they had to be mitotically inactivated. 
Mitosis was inhibited by treating the EF cells with mitomycin C (MMC)(10 µg/ml, Sigma) 
for 2-5 hours. Afterwards, cells were washed twice with PBS to remove residual MMC and 
trypsinized. The single cell suspension was plated on the desired plates with fresh EF 
medium. Usually the plates were gelatinized beforehand. MMC treated feeder cells were used 
as basal layer for ES culture. 
2.3.7 Murine Embryonic Stem Cells 
ES cells are derived from the inner cell mass of a three and a half day old mouse 
embryo, the blastocyst and maintained in culture (Evans and Kaufmann, 1981; Martin, 1981). 
ES cells are pluripotent giving them the potential to develop into all cell types or even 
produce a whole animal. 
Murine ES cells are accessible for experimental genetic manipulation in vitro (Gossler et 
al., 1986; Robertson et al., 1986) and can be reinjected afterwards into blastocysts. The 
injected blastocysts are then transferred into pseudo pregnant recipient mothers. The 
manipulated ES cells can contribute to the embryo formation resulting in the generation of 
chimeric mice. Chimeric founders possess a mixed coat color pattern because usually 
blastocysts and ES cells are derived from mouse strains with different coat color. The 
chimeric mice are used as an indicator for the contribution of the modified ES cells in 
embryogenesis. To achieve a high rate of chimerism and germline transmission, the culture 
conditions must guarantee the undifferentiated state of the ES cells (Smith, 1992). This is 
obtained by culturing the cells on a layer of mitotically inactive murine fibroblasts (feeder 
cells) and the addition of the cytokine LIF (leukemia inhibitory factor) to the ES cell medium 
(Smith et al., 1988). LIF specifically suppresses differentiation of pluripotent ES cells without 
compromising their developmental potential. 
The ES cells form colonies with a defined shape which have to be checked by 
microscopy on a daily basis to avoid differentiation. Before the colonies lose their blank 
borders and touch each other they have to be passaged onto a new feeder layer. The success of 
germline transmission is highly dependent on the quality of cell culture.  
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2.3.7.1 Transfection of ES Cells 
The cloned targeting vector was linearized via endonuclease digestion and after protein 
contaminations were removed with a phenol-chloroform extraction the DNA was stored in 70 
% (v/v) ethanol to guarantee sterility. Approximately 40 µg of DNA were used to transfect 
1x107 ES cells. 
Four days prior to transfection ES cells were thawn. The cells were passaged two days 
later. Four hours before transfection, the medium was replaced by fresh ES cell medium. The 
cells were trypsinized and counted. 1x107 cells were sedimented and resuspended in 400 µl of 
transfection buffer. The linearized targeting vector was dissolved in 400 µl of transfection 
buffer and added to the ES cells. The mix was transferred to an ice-cold electroporation 
cuvette (Gene Pulser cuvettes, 4 mm, BioRad, Germany). Electroporation was performed with 
a GenePulser Electroporator (BioRad, Germany) at 240 V and 500 µF. Afterwards, the cells 
were incubated at room temperature for 10 min, resuspended in ES medium and plated on 4-6 
MMC-treated EF cell covered 10 cm plates. 
2.3.7.2 Selection for Targeted Clones in Culture 
After transfection of the ES cells with a targeting construct, one has to select for cells 
which have incorporated the linearized vector by use of a positive selection marker. The 
targeting vectors contain the neomycin resistance gene (neoR) that allows the isolation of all 
ES cell clones that stably incorporated the construct into their genome. Positive selection was 
performed by drug selection with the neomycin analogon G418. Positive selection was started 
at day 2 after transfection by feeding the cells with medium supplemented with G418 (225 
µg/ml active concentration, Gibco/BRL). The cells were kept under G418 selection 
throughout the whole screening procedure. 
Since integration of the targeting construct can either be random or homologous, the 
targeting construct often also contains a negative selection cassette at its 3’ end. During 
homologous recombination this cassette is lost whereas random integrants usually integrate it 
into the genome (Folger et al., 1982). The targeting vector contains the thymidine kinase gene 
from the Herpes simplex virus (HSV-TK). Starting at day 5 after transfection the negative 
selection drug ganciclovir (GANC) is added to the G418-containing ES medium (final 
concentration of GANC 2µM). After intracellular expression, the thymidine kinase 
phosphorylates GANC to GANC-monophosphate that is further phosphorylated to GANC-
triphosphate by cellular enzymes. GANC-triphosphate is incorporated into newly synthesized 
DNA during replication that finally leads to cell death. Therefore, application of GANC 
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represents an approach to select against random integration events, whereas homologous 
recombinants will not be affected by the drug since they have lost the HSV-TK gene. 
2.3.7.3 ES Cell Screening in 96-well Microtiter Plates 
Screening the targeted ES cells in 96-well plates is a very efficient approach to screen 
large numbers of transfected cells. 
After 8-10 days of drug selection the surviving colonies need to be analyzed for proper 
integration of the targeting construct into the genome. To this end, colonies had to be isolated, 
one colony per well of a 96-well plate, and grown for later analysis. 
The cells were washed twice with 10 ml 1 x PBS. Plates were covered with 10 ml 1 x 
PBS and single colonies were picked with a pipette in a volume of 20 µl. Only colonies with a 
round shape and bright color were chosen. Each clone was placed in a well of a round-bottom 
96-well plate together with 50 µl of 1 x trypsin. After 20 -30 min of picking colonies, the 96-
well plate was incubated for 3- 4 min at 37°C. Afterwards 80 µl of ES cell medium was added 
per well to stop the trypsinization of the cells. After picking is finished, the 150 µl of cell 
suspension in each well were distributed onto three wells of gelatinized EF-covered 96-well 
flat-bottom plates. ES medium was added to a final volume of 200 µl per well. The plates 
were placed in an incubator and grown for 3- 4 days with daily exchange of medium. Cell 
growth was monitored daily to ensure optimal growing conditions.  
Two plates were frozen as a backup storage for subsequent recovery of positive clones. 
For this purpose the plates were washed twice with 100 µl of PBS per well and then 
trypsinized in 50 µl of 1 x trypsin for 3 min at 37°C. The reaction was stopped by adding 100 
µl of ES cell medium. 100 µl of ice-cold freezing medium (20 % DMSO (v/v) in ES-FCS) per 
well were added, the plates were sealed with parafilm and slowly frozen at – 80°C.  
The third plate was grown to confluency, washed with PBS, trypsinized and split onto three 
gelatinized 96-well flat-bottom plates. These plates were grown to confluency and used to 
prepare ES cell DNA for Southern blot analysis. After removal of the ES medium and 
washing with 100 µl PBS per well, two of the three plates were frozen at - 20°C. ES cells of 
the third plate were used for DNA isolation as described previously. The air-dried DNA was 
digested in a volume of 35 µl per well, electrophoretically separated and analyzed by 
Southern blot hybridization as described previously. 
2.3.8 HTNC Treatment 
2x105 ES cells were plated in a well of a 6-well culture dish with MEFs, 5 h prior to 
HTNC treatment. The medium was removed and replaced with DMEM without FCS/PBS, 
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1:1, 4-0.25 µM HTNC from a 50% (v/v) glycerol stock solution of 180 µM HTNC for 20 h 
(Peitz et al., 2002; M. Peitz, unpublished). Thereafter, the cells were cultured as described 
above. The deletion efficiency at 2 µM HTNC was usually 97%. 
2.3.8.1 Preparation of Targeted ES Cell Clones for Blastocyst Injection 
Five days prior to injection a vial of ES cell clones was thawn on a EF cell covered 10 
cm plate. After two days the cells were split according to cell numbers on 10 cm plates. On 
the day of injection the best-looking plate was prepared. The ES cells were washed twice PBS 
and trypsinized. The single cell suspension was centrifuged for 5 min at 1200 rpm at 4°C. The 
supernatant was removed and the pellet resuspended in 10 ml of ES medium. The cells were 
plated on a gelatinized 10 cm plate and incubated for 30- 40 min at 37°C. The majority of the 
ES cells stay in the supernatant whereas the EF cells attach to the plastic. Different fractions 
were taken after the incubation: 
The supernatant containing the ES cells was pipetted into a 15 ml tube (fraction 1). 
Afterwards the plate was washed with 10 ml ES medium and the resulting cell suspension was 
transferred into a second 15 ml tube (fraction 2). Samples of both fractions were checked 
under the microscope for purity and amount of cells. The cell fractions were centrifuged at 
1200 rpm for 5 min at 4°C. The supernatant was discarded. the pellet resuspended in 500 µl of 
ice-cold injection buffer and kept on ice (Torres and Kühn, 1997; Stewart, 1993). 
 
Blastocyst Medium     Injection Medium 
250 ml DMEM (Gibco/BRL)    250 ml blastocyst medium 
45 ml EF-FCS (Gibco/BRL)    0.0375 g DNase A 
3 ml sodium pyruvate (Gibco/BRL)   stored in 5 ml aliquots at – 20°C 
3 ml non- essential amino acids (Gibco/BRL) 
3 ml penicillin/ streptomycin (Gibco/BRL) 
3 ml L- glutamine (Gibco/BRL) 
8.35 ml HEPES (Gibco/BRL) 
 
2.3.8.2 Blastocyst Injections and Transfers 
The prepared ES cells were microinjected with a Leica micromanipulator into 
precultured blastocysts derived from CB20 mice. The injection of 129/OLA ES cells into 
CB20 mice with white coat color resulted in offspring with brown-white coat color 
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chimerism. The injection of Bruce-4 ES cells derived from black-colored C57BL/6 mice into 
CB20 mice will result in offspring with black-white coat color chimerism. 
10- 15 ES cells were injected in each of the blastocysts and cultured in blastocyst 
medium prior to transferring them into recipient foster mice. These mice are pseudopregnant 
CB20 mice that were previously mated with vasectomized male mice. 
2.3.9 Preparation of Single Cell Suspensions From Lymphoid Organs 
Mice were killed and the organs of interest were taken and placed in ice-cold PBS. 
Single cell suspensions were prepared by passing the organs through a mesh or sieve. Cells 
were stored in ice-cold PBS-BSA-azide (PBA). It is important to keep the cells in PBA to 
prevent capping of the antibodies during the staining procedure. The azide shuts down the cell 
metabolism which prevents the metabolization of the antibody. Cells from spleen were 
pelleted (5 min, 1200 rpm, 4°C) and resuspended in 1 ml red blood cell lysis buffer to lyse 
erythrocytes. After a three minute incubation at room temperature, the reaction was stopped 
by diluting the lysis buffer with 10 ml ice-cold PBA. Cells were collected by centrifugation 
and resuspended in PBA. The cell numbers of the different single cell suspensions were 
determined. 
 
PBA     Red Blood Cell Lysis Buffer 
PBS with     1 volume of 8.3 g/l NH4Cl 
1 % (w/v) BSA   9 volumes of 20.59 g/l Tris/HCl pH 7.6 
0.01 % (w/v) sodium azide 
Stored at 4°C 
2.3.10  Preparation of Peripheral Cells from Mouse Blood 
In order to obtain approximately 100-200 µl mouse blood, the tail vein was cut with a 
razor blade. The blood was mixed directly with 10 µl of Heparin (Liquemin N500). 500 µl of 
room temperature Ficoll (7 %, v/v) were added to fresh tubes. The blood was carefully 
pipetted on top of the Ficoll layer followed by centrifugation (5 min at 4000 rpm, room 
temperature). The uppermost phase was transferred into a fresh tube together with 1 ml PBS. 
After another round of centrifugation (3500 rpm, 5 min at room temperature) the cells were 
ready to be stained for FACS analysis. 
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2.3.11  Flow Cytometry 
Single cell suspensions were prepared from all tested organs. Red blood cells from LN 
and spleen were lysed in cell suspension with Tris-ammoniumchloride, pH 7.2. Cells (106 per 
sample) were surface stained in 30 µl PBS, 0.1% (w/v) BSA, 0.01% (w/v) NaN3 with 
combinations of fluoresceine isothiocyanate (FITC), phycoerythrine (PE) and Cy-ChromeTM 
(Cyc), APC or bio-conjugated mAbs for 20 min on ice. Stainings with biotinylated mAbs 
were followed by a secondary staining step with Streptavidin-CychromeTM (Pharmingen). 
After staining, the samples were washed and resuspended in PBS-BSA-NaN3. Stained cells 
were analysed on a FACSCalibur and data were evaluated using CellQuest software (Becton 
Dickinson, Mountain View, USA). Dead cells were labeled with Topro-3 and excluded from 
the analysis. Monoclonal antibodies, listed in Table 1, were either homemade (C. Uthoff-
Hachenberg, B. Hampel, Institute for Genetics, Cologne, Germany) or purchased from 
Pharmingen (San Diego , USA). 
Specificity Clone Reference and Supplier 
IgM R33-24.12 (Gruetzmann, 1981), lab-made 
IgD G12-47/30 (Seemann et al., 1981), lab-made 
B220/CD45R RA3-6B2 (Leo et al., 1987), Pharmingen 
CD4 GK.1.5/4 (Dialynas et al., 1983), Pharmingen 
CD5 53-7.3 (Ledbetter and Herzenberg, 1979), Pharmingen 
CD8 53-6.7 (Ledbetter and Herzenberg, 1979),Pharmingen 
CD19 1D3 (Springer et al., 1979), Pharmingen 
CD21/CD35 7G6 (Kinoshita et al., 1988), Pharmingen 
CD22 Cy34.1 (Symington et al., 1982), Pharmingen 
CD23 B3B4 (Rao et al., 1987), Pharmingen 
CD24/HSA M1/69 (Springer et al., 1979)Pharmingen 
CD25 (IL2Rα) 7D4 (Malek et al., 1983), Pharmingen 
CD43 S7 (Gulley et al., 1988), Pharmingen 
CD62L (L-Selectin) MEL-14 (Gallatin et al., 2006), Pharmingen 
CD69 H1.2F3 (Yokoyama et al., 1988), Pharmingen 
CD86/B7.2 GL1 (Inaba et al., 1994), Pharmingen 
CD90.2/Thy1.2 CFO-1 (Opitz et al., 1982), Pharmingen 
CD95/Fas Jo2 Pharmingen 
AA4.1 AA4.1 Pharmingen 
BP-1 BP-1 (Cooper et al., 1986), Pharmingen 
c-Kit c-Kit Pharmingen 
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Fas Fas Pharmingen 
MHC II M5/114 (Bhattacharay et al., 1981), Pharmingen 
IgG1 IgG1 Pharmingen 
PNA PNA Pharmingen 
Table 2: List of antibodies used for flow cytometry  
2.3.12 Magnetic Cell Sorting and FACS Sorting 
Specific cell populations were either sorted or depleted from a heterogenous cell 
suspension by magnetic cell sorting (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany). 
Cell populations were labeled with antibody-coupled microbeads (10 µl beads, 90 µl PBS-
BSA-N3 per 107 cells) and separated on VS or CS MACS columns in a magnetic field 
(Miltenyi et al., 1990)). For cell sorting, B cells were purified by MACS and then stained with 
antibodies against various cell surface markers. B cells of individual B cell subsets were then 
sorted using a dual laser FACStar (Becton Dickinson, Franklin Lakes, USA). The purity of 
isolated populations was subsequently tested by FACS analysis: MACS-isolated B cells were 
normally >80% pure and sorted B cell subpopulations were 95% pure.  
2.3.13  B Cell Receptor Internalization 
To measure endocytosis, splenocytes were preequilibrated at 4°C in RPMI 0.5% FBS 
and incubated with either biotin goat anti–mouse IgM Fab' or goat anti–mouse IgM (Fab')2. 
Cells were then either fixed in 0.5% paraformaldehyde in PBS (To) or incubated at 37°C for 
the indicated times (Tn) before termination with 0.5% paraformaldehyde in PBS. Fixed cells 
were stained with PE-B220 and streptavidin Red 670 (Invitrogen), and surface BCR 
expression was determined by flow cytometry. Percent internalization was calculated by the 
formula [MFI sIgM(T0) – MFI sIgM(Tn)]/MFI IgM(T0) x 100. 
2.3.14  Calcium flux 
Splenic cells were labeled with Fluro 3 (Molecular Probes), and calcium flux of B cells 
resuspended in 106 cell/ml RPMI 2% FCS was assayed by measurement of emission of FL1 
channel in the BD Calibur.  
2.3.15 Culture of ex vivo Splenocytes and Lymphocytes 
The spleens were aseptically removed from mice and then pressed through a sterile 
sieve. Erythrocytes were lysed for 2 min by NH4Cl (140 mM NH4Cl, 17 mM Tris-HCl pH 
7.65). Splenocytes were kept in DMEM supplemented with 10% (v/v) FCS, 1 mM sodium 
pyruvate, 2 mM L-glutamine, 1x non-essential amino acids, 0.1 mM 2-β-mercaptoethanol 
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supplemented with various activation compounds (LPS; ConA; PMA; BAFF) for no longer 
than four days.  
2.3.16 CFSE Labeling and in vitro B cell Activation 
B cells were purified using MACS (as described above). For activation marker studies 
1.5 to 4x 106 cells were plated in a 24-well plate and analysed after 24 h. Supernatants were 
collected for cytokine analysis. For proliferation analysis, B cells were resuspended in 1 ml 
per 107 cells 2.5 µM CFSE (5mM stock in DMSO, Molecular probes) in PBS at RT for 6 min 
((Lyons and Parish, 1994)). The labeling reaction was stopped by addition of 10 ml DMEM/ 
10% (v/v) FCS medium. The cells were then washed once in medium. Labeled B cells were 
plated at 0.5x 106 cells per well in round bottom 96-well plates. The cells were incubated in 
DMEM medium plus 10% (v/v) FCS, untreated or treated with 5 µg/ml anti-CD40, anti-IgM 
(5 µg/ml), LPS (2 µg/ml) and LPS plus IL-4 (5 ng/ml) with or without BAFF (100 ng/ml). 
Labeled cells were analysed after various time points.  
2.3.17 Induced Class Switch Recombination 
Using the MACS system, B cells were isolated from various mice. 4x 106 B cells were 
incubated in 24-well plates for 5 days in the presence of 10 µg/ml LPS plus 20 ng/ml IL-4 or 
2 ng/ml TGF-β. Thereafter, the B cells were analysed for the expression of IgG1 or IgA by 
flow cytometry. 
2.3.18 Histological Analysis and Immunohistochemistry 
Shock frozen tissues were sectioned in 5-8 µm slices, fixed in ice cold acetone for 10 
min and air dried for 10 min. Using a Pap pen, the tissue was outlined on the glass slide, 
placed in a wet chamber, and TBS was added for 5 min at RT.  Slides were then incubated 
with quenching buffer containing 0.3% (v/v) H2O2 for 30 min and washed once with TBS. 
The sections were incubated with avidin solution and biotin solution for 15 min each and 
subsequently washed three times with TBS. The sections were then incubated with the 
primary antibodies for 60 min. After incubation, the sections were washed three times with 
TBS and incubated with secondary reagents Peroxidase-Streptavidin 1:500; Alkaline 
Phosphatase Goat anti-Rat 1:50 containing 5% (v/v) mouse serum for 60 min. Sections were 
washed three times with TBS. The slides were incubated with freshly prepared POX solution 
for 10 min and subsequently washed with TBS. The AP was developed using the Alkaline 
Phosphatase Substrate Kit III, washed three times with TBS and air dried before mounting 
with glycerol or crystal mount. 
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Dissected testes were fixed in Bouin solution for 24 h, processed, and paraffin-
embedded using standard protocols. The initial morphology of testes was examined after 
hematoxylin and eosin staining of 5 µm sections. 
2.3.19 Preparation and Immunostaining of Cytospins 
In order to evaluate the expression levels of different proteins in B cells, cytospins 
were prepared. Therefore, 2 x 105 B cells were centrifuged on glass cover slips (5 min at 
maximum speed) resulting in cell spots and stored at –80°C.  
Cytospins of purified B cells were fixed in acetone for 10 min at –20°C and stained 
according to standard methods, using rabbit IgG antibody (Santa Cruz, Heidelberg, Germany). 
All incubation steps during the staining procedure were carried out at RT. The cytospins were 
counterstained with Hoechst 33258. 
2.3.20 Protein Extract Preparations 
Protein lysates from mouse organs were prepared either freshly or from frozen tissue. 
Tissue was diced into small pieces using a clean razor blade. Then, RIPA buffer (1x PBS, 1% 
(v/v) NP-40) was added at 3 ml/g tissue supplemented with various protease inhibitors. 
Samples were centrifuged at 13,000 rpm for 5 min to separate supernatants from debris. 
Supernatants were transferred to fresh tubes and protein concentrations were determined in a 
photometer using Bradford assay (Ref). Protein extracts were diluted with RIPA buffer to 15 
mg/ml before adding running buffer (3 x SDS sample buffer, NEB, Schwalbach, Germany) 
and DTT (30x DTT, NEB, Schwalbach, Germany) to 200 µg of protein extracts. To separate 
the cytoplasmic protein fractions from the nuclear extracts, cells were resuspended at 106/15 
µl in hypotonic solution (10 mM Hepes [pH 7.9], 10 mM KCl, 2 mM MgCl2, 0.5 mM DTT, 
0.1 mM EDTA, supplemented with various protein inhibitors) and incubated at 4 °C for 10 
min. Then NP-40 was added to 1% (v/v) and the cells were centrifuged at 13,000 rpm for 1 
min. The supernatant containing the cytoplasmic fraction was recovered from the nuclear 
pellet and the nuclear pellet was resuspended in 106 cells per 10 µl of high salt buffer (20 mM 
Hepes [pH 7.9], 420 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.2 mM EDTA and 10% (v/v) 
glycerol) and incubated on ice for 30 min. Nuclear extracts were recovered after 
centrifugation at 10,000 rpm for 10 min at 4 °C and stored at – 80 °C. 
2.3.21 Western Blot 
Protein extracts were electrophoresed by SDS-PAGE (8-15% (v/v)) (Laemmli, 1970) 
and transferred to Immobilon-PVDF membranes (Millipore, Bedford, USA). The membranes 
were blocked with 5% (w/v) NF-milk/PBS or 5% (w/v) BSA/PBS for 1 h and probed using 
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primary antibodies. Membranes were then incubated with goat anti-rabbit IgG-horseradish 
peroxidase (HRP) conjugates (Vector, Burlingame, USA) as secondary antibody and 
developed using the ECL or ECL+ kit. 
 
Specificity Clone/Supplier 
β-Actin (AC-40, Sigma) 
Akt (9272,Cell signaling)  
PY99 (C-14; Santa Cruz) 
Btk (3532, Cell signaling) 
pBtk (3537, Cell signaling) 
IκBα (C21, Santa Cruz) 
p-IκBα (B9, Santa Cruz) 
p38 (9212, Cell signaling) 
p-p38 (9215, Cell signaling) 
Jnk (FL7, Santa Cruz) 
p-Jnk (G7, Santa Cruz) 
Syk (2712, Cell signaling) 
p-Syk (2711, Cell signaling) 
Lyn (2732, Cell signaling) 
p-Lyn (2731, Cell signaling) 
Table 3: List of antibodies used for Western Blotting 
 
2.4 Mouse Experiments 
Tail bleeding as well as the general handling of mice was performed according to 
Hogan (Hogan et al., 1987) and Silver (Silver, 1995). 
2.4.1 Mice 
C57BL/6 mice were obtained from Charles River or Jackson Laboratories. CD19-Cre 
mice (Rickert et al., 1997) and Flp deleter mice ((Rodriguez et al., 2000)were intercrossed 
with the Smad7FL/FL mouse strain in conventional facilities. 
 
Name of primer Sequence Purpose 
Luz6 CCT TCC TCC TAC CCT ACA AGC C Used for typing of the IgM 
and IgG1 locus 
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Luz8 AGG ACG AGG GGG AAG ACA TTT G Used for typing of the IgM 
and IgG1 locus 
γ1-389 CAG ATG GGG GTG TCG TTT TGG CTA C Used for typing of the IgM 
and IgG1 locus 
4532-FOR GCA GCA GGC GTC GGG Used for typing of the Igα 
locus 
4815-wt-REV AGG CAG GAT GCT GGA GT Used for typing of the Igα 
locus 
2017-FOR TTC CCC GAA GTA AAC AAG AAC Used for typing of the Igα 
locus 
3026-REV TGG AAG GAC AAA CCT TGG AA Used for typing of the Igα 
locus 
INTRO-REV CAG GGG TCA GAG AGG AGA CA Used for typing of the Igα 
locus 
B29 I4-FW GAG ACT CTG GCT ACT CAT CC Used for typing of the Igβ 
locus 
B29 6R CCT TCA GCA AGA GCT GGG GAC Used for typing of the Igβ 
locus 
IRES-R CGA CAT TCA ACA GAC CTT GC Used for typing of the Igβ 
locus 
S7 FLOX5 GTC AGG TTG GAT CAC CAT GCC Used for typing of Smad7flox 
and Smad7del 
S7 FLOX3 GAC TGC CTG GAG AAG TGT GTC Used for typing of Smad7flox 
S7 DEL3 TCT CCA TCC TAC CAC TGC CC Used for typing of Smad7del 
Table 4: Primer used for typing 
 
 
2.4.2 NP-CG Immunization 
Primary T cell dependent responses were induced with alum precipitated NP-CG (4-
hydroxy-3-nitrophenylacetyl chicken-γ-globulin) (Weiss and Rajewsky, 1990). The antigen 
was prepared by mixing 1 volume of NP-CG (1 mg/ml in PBS) with 1 volume of 10% (w/v) 
KA1(SO4)2. The solution was adjusted to pH 6.5 and kept 30 min on ice. Then, the precipitate 
was washed three times in PBS and resuspended in PBS. Mice were immunized by i.p. 
injections of 50 µg NP17-CG in a volume of 200 µl.  
2.4.3 ELISA 
Ig serum concentrations to NP were determined with ELISA as described previously 
(Roes and Rajewsky, 1993). Briefly, microtiter plates (Greiner, Frickenhausen, Germany) 
were coated with NP14-BSA at 4°C o/n, and subsequently blocked at RT for 30 min in 0.5% 
(w/v) BSA. Next, serially diluted sera samples were applied to the wells and incubated at 
37°C for 1 h together with the standard. Secondary biotinylated antibody was then added for 1 
h at 37°C. Detection of the biotinylated anti-sera was achieved with SA-conjugated alkaline 
phosphatase (AP, Boehringer: 30 min at RT) and p-nitrophenylphosphate as substrate 
(Boehringer). Following each incubation step, unbound antibodies or SA-conjugated AP were 
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removed by five washes with tap water. The OD405 was measured with an ELISA-photometer 
(Anthos 2001, Anthos Labtech Instruments, Salzburg, Austria) and the relative antibody 
concentration were determined by calculating the association constant as described by 
Cumano and Rajewsky (Cumano and Rajewsky, 1986), following a method developed by 
Herzenberg et al. (Herzenberg et al., 1980).  
 
Coating Biotin-Conjugate Specificity Standard 
R33-24.12 gam IgM (SBA) IgM B1-8µ 
gam IgG1 (Sigma) gam IgG1 (SBA) IgG1 N1G9 
ram IgG2aa (Nordic) gam IgG2a (SBA) IgG2aa 41.2-3 
G12-47/30 G1247/30 IgG2ab S43-10 
R14-50 IgG2b (SBA) IgG2b D3-13F1 
2E.6 IgG3 (SBA) IgG3 S24/63/63 
95.3 ram IgE (Pharmingen) IgE B1-8e 
IgA gam (Sigma) gam IgA (SBA) IgA 233.1.3 
Table 5: Antibody combinations to determine serum antibody isotypes 
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3 Results 
3.1 Generation of IgG1i mice 
In the generation of B cell memory, most of the antigen-activated B cells participating in 
the response switch to the expression of IgH chains of the classes γ, ε and α, and the BCR on 
these cells acquire the cytoplasmic tail of the newly expressed IgH chain as an additional 
signaling module (Geisberger et al., 2003; Neuberger et al., 1989; Reth, 1994). The functional 
importance of this module has been investigated in the some of the transgenic mouse models 
expressing the γ chains (Lutz et al., 1998; Roes and Rajewsky, 1991). However, the 
physiological significance of these experiments remained uncertain, given the variations in 
transgene copy number and consequently expression levels inherent in the experimental setup. 
To investigate the physiological role of γ1 chain containing B cell receptor (BCR), using the 
technique of gene targeting, a new mouse model, termed IgG1i, was generated in our 
laboratory. In this model the γ1 constant region (Cγ1) gene segment replaced the µ constant 
region (Cµ) in the mouse germ line. This was achieved by constructing a mouse strain whose 
IgH constant region gene cluster is replaced by a loxP-flanked simplified locus containing a 
Cµ and a Cγ1 gene segment in opposite orientation (Fig. 6).  
 
Fig. 6 Genomic structure of the IgG1i locus. 
All IgH constant regions were replaced by the Cγ1 region followed by the Cµ region in opposite transcriptional 
orientation flanked by inverted loxP sites to generate the IgG1i allele. B cells carrying the IgG1i allele express 
exclusively a BCR of the IgG1 isotype. Cre recombinase activity can be employed to switch the loxP-flanked 
region towards the exclusive expression of a BCR of the IgM isotype (IgMi allele). 
3.2 Generation of IgαΔc/IgG1i, IgβΔc/IgG1i and IgαΔc/IgβΔc/IgG1i 
mice 
The BCR consists of the membrane immunoglobulin (mIg), and a signaling subunit, a 
disulfide-linked heterodimer of the Igα and Igβ proteins that are non-covalently associated 
(Fig. 7). Igα and Igβ each contain a single immunoreceptor tyrosine-based activation motif 
(ITAM) within their cytoplasmic tail that initiates signal transduction following BCR 
aggregation (Flaswinkel and Reth, 1994). 
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The signaling of IgM expressing BCR is known to rely entirely on the cytoplasmic tail 
of Igα/Igβ (Reichlin et al., 2001). This is evidenced by the severely compromised B cell 
development in mice carrying a mutation in the cytoplasmic part of Igα or Igβ (Kraus et al., 
1999; Reichlin et al., 2001). Both mouse strains generate less than one percent of mature B 
cells compared to WT mice. Mice with a truncated Igα chain have a block in B cell 
development between the pro- and pre-B cell stages, whereas mice with truncated Igβ co-
receptor show a less severe block in B cell development, allowing the cells to develop to the 
immature stage. This unique biological function of Igα and Igβ might result from distinct 
signal transduction through their cytoplasmic tails. Since membrane-bound IgG1 also contains 
a cytoplasmic tail, it is of interest to assess whether the tail of Igα or Igβ is required for signal 
transduction of IgG1 BCR. Therefore, we bred mice homozygous for the Igα mutation (IgαΔc) 
while homo- or heterozygous for IgG1i (IgαΔcIgG1i). Likewise, mice homozygous for the Igβ 
mutation (IgβΔc) and homo- or heterozygous for IgG1i (IgβΔcIgG1i) were also bred. We also 
produced triple mutant mice (IgαΔcIgβΔcIgG1i), which are homozygous for the Igα truncation 
mutation and homozygous for the Igβ truncation mutations in addition to the γ1 insertion. 
(Fig.7) 
                  WT                                    IgαΔc                                     IgβΔc                               IgαΔc/IgβΔc 
 
 
 
 
 
 
 
 
                  IgG1i                            IgαΔc/IgG1i                          IgβΔc/IgG1i                    IgαΔc/IgβΔc/IgG1i 
 
Fig. 7  BCR/Igα/Igβ  mutant mice 
The BCR consists of the membrane immunoglobulin (mIg), and a signaling subunit, a disulfide-linked 
heterodimer of the Igα and Igβ proteins. To investigate the interaction between immunoglobulin and Igα/Igβ, 
we crossed the IgG1i mice to IgαΔc or IgβΔc mice to get IgG1i/IgαΔc, IgG1i/IgβΔc and IgG1i/IgαΔc/IgβΔc mice. 
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3.2.1 IgG1 affects B cell compartments distinctly and diversely when in 
combination with intact or mutant Igα  and Igβ  BCR subunits 
All the above mutant mice are viable and do not demonstrate any differences in 
survival capacity compared to WT mice. However, the B cell compartments differ between 
the different mouse strains. We detected that IgG1i mice contain a decreased population of 
lymph node and splenic B cells compared to WT mice (IgG1i: 33% 34% WT: 40% 59%). In 
the Igβ mutant mice in combination with the IgG1i allele (IgβΔcIgG1i), a three-fold decrease 
of the B-lymphocyte proportion was detected compared to the Igβ mutant mice (IgβΔc) (IgβΔ
cIgG1i: 0.4% 0.3% IgβΔc: 0.2% 0.1%). In contrast to the decreased B cell compartment in 
these two IgG1 expressing mouse strains, a four-fold increased population of B-lymphocytes 
was observed in the lymph nodes and spleen of the Igα mutant mice in combination with 
IgG1i (IgαΔcIgG1i) compared to the Igα mutant mice (IgαΔc) (IgαΔcIgG1i: 3% 3.3% IgαΔc: 
0.8% 0.8%). (Fig.8) 
 
Fig. 8 B cell compartments in the spleen and lymph nodes 
Flow cytometry of lymphocytes isolated from the depicted organs of mice with the indicated genotypes using 
B220 and CD90 antibodies. The numbers in the quadrants represent percentage of the gated population. 
 
Next, we assessed whether the changed proportion of B cells in the mutant mice was 
consistent with the numbers of B cells. As seen in the Fig. 9, the B cell numbers matched the 
B cell proportions. As IgG1i mice contained a slightly reduced number of B cells compared to 
WT mice, IgβΔcIgG1i mice exhibited a 1,5-fold decrease in the number of B cells compared 
to the IgβΔc mice (IgβΔcIgG1i: 0.05+0.01 IgβΔc: 0.07+0.02). Consistent to the B cell 
proportion, we noticed the pronounced increase of B cells in the IgαΔcIgG1i mice compared 
to IgαΔc mice (IgαΔcIgG1i: 3.18+0.7 IgαΔc: 0.21+0.02). These results indicate that IgG1 
signaling is able to partially restore splenic and lymph node B cell compartments in 
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genetically challenged mice lacking functional Igα via compensatory signaling through the 
Igβ subunit.  
          
Fig. 9 Total B cells number in the spleen 
Bar charts of total B cells numbers in spleen of indicated mice. 
3.2.2 IgG1 expression compromises B cell development in the BM. 
The BCR light chains are composed of protein expressed from two gene families, 
namely κ light chain and λ light chain. The majority of B cells express κ light chains and only 
a small population of B cells expresses an λ light chain. Previous studies reported that 
aberrant B cell development could result in increased usage of λ chain (Lang et al., 1996; 
Tiegs et al., 1993). In light of this finding, we opted to use increased lambda chain expression 
on B cells as a peripheral ‘readout’ for aberrant B cell development. We initially observed 
that IgG1i mice contain 12% λ+ B cells whereas WT mice exhibit normally five percent, 
indicating a compromised B cell development programme in the absence of IgM (Fig.10). 
Igα-deficient mice (IgαΔc) presented with an increased proportion of lambda-expressing B 
cells in the periphery when compared to WT controls. This increase was further aggravated in 
mice lacking only the Igβ (IgβΔc), thus implicating a more important role for Igβ signaling 
with IgM in determining the expression of lambda light chains. This trend was reproducible in 
IgG1i mice lacking Igα and Igβ. (Fig.10). These results indicate that untimely signaling 
through the Igα or  Igβ subunit will result in an up-regulated expression of lambda light 
chains on the B cells. Thus, we proceeded to investigate the BM B cell development in those 
mice. 
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Fig. 10 FACS analysis of B cell development in the spleen of IgG1i/mutant mice 
Splenic cells were gated on CD19+ cells and stained for the expression of the cell surface markers κ and λ. The 
numbers refer to the percentages of the specific cells population gated on live lymphocytes. 
 
B-lymphocytes follow a highly ordered program of development in the bone marrow 
(BM), beginning with the commitment of lymphoid progenitors to the B lineage and 
proceeding from pro-B cells to pre-B cells and finally to immature B cells that either undergo 
negative selection or enter peripheral organs (Edry and Melamed, 2004). 
We detected an increase in the pro-B cell (c-Kit+) fraction of IgG1i mice compared to 
WT mice (Fig.11A). This increase was also observed in the Igα or Igβ truncated mice (IgαΔc 
 65%,  IgβΔc  40%), which appeared to be more severe in combination with the γ1 heavy chain 
(IgαΔcIgG1i 70% or IgβΔcIgG1i 52%). Furthermore, we found that the increased populations 
of pro-B cells are paralleled with decreased proportions of pre-B cell in the all the IgG1 
expressing mice (Table.6).  Thus, the γ1 expression compromised the transition from pro- to 
pre-B cells and its combination with Igα or Igβ mutation consequently results in synergic 
developmental block in the IgαΔcIgG1i mice as well as in the IgβΔcIgG1i mice (Fig.11A, 
Table.6).  
To evaluate the transition from pre-B to immature B cells, BM cells were stained with 
B220, AA4.1 and CD43 as well as CD25 antibodies. As observed in Fig.11B, the proportions 
of immature B cell (B220+AA4.1+CD43-CD25-) are increased relative to their decreased pre-
B cell population (B220+AA4.1+CD43-CD25+) in the IgG1 expressing mice. However, when 
the total cell numbers in all the six mouse strains were compared, we found that the actual 
numbers of immature B cells in the BM from IgG1 expressing mice were comparable and 
equal to those their wild type counterparts, indicating a true representation of altered BM 
subsets (Fig.11B, Table.6).  
In summary, we observed that mice expressing IgG1 (IgG1i, IgαΔcIgG1i and IgβΔ
cIgG1i) exhibit a more severe block at the transition from pro-B to pre-B cell stage compared 
to non-IgG1 expressing mice (WT, IgαΔc and IgβΔc). This was shown by the accumulation of 
pro-B cells and the reduction of pre-B cells in those mice expressing IgG1 (Table.6). 
However, in spite of the decreased population of pre-B cells, the immature B cells in the IgG1 
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expressing mice are comparable to non-IgG1 expressing mice (Table.6). This indicates that 
the increased number of peripheral B cells in the IgαΔcIgG1i mice compared to IgβΔcIgG1i 
mice did not come from an advantage in the BM B cell development, but rather from a 
peripheral influence. 
 
Fig. 11 FACS analysis of B cell development in the BM of IgG1i/mutant mice 
BM lymphocytes were prepared from the indicated mice. (A) Cells were gated on B220+Ig- cells and stained 
with the pro-B cells marker c-kit. (B) B220+AA4.1+CD43- cells were gated to analyze the ratio of CD25+ vs. 
CD25- cells. The numbers in the quadrants refer to the percentages of the specific cells population gated on live 
lymphocytes. 
 
  Percentage of all bone marrow cells   
Mice No. Pro-B 
(A-C) 
Pre-B 
(D) 
Immature 
(E) 
Recirculating 
(F) 
WT  N=4 3.52 + 0.56 10.4 + 1.79 6.67 + 1.13 5.87 + 1.10 
IgG1i  N=4 5.80 + 0.92 1.16 + 0.20 5.29 + 0.90 1.61 + 0.28 
IgαΔc  N=4 19.8 + 3.41 1.41 + 0.24 5.30 + 0.89 0.05 + 0.01 
IgαΔcIgG1i  N=4 18.5 + 2.94 0.41 + 0.07 5.47 + 0.93 0.16 + 0.02 
IgβΔc  N=4 9.76 + 1.54 6.21 + 1.07 4.31 + 0.73 ND 
IgβΔcIgG1i  N=4 13.8 + 2.19 0.52 + 0.09 6.01 + 1.01 ND 
Table 6: B cell numbers in the BM  
The mean averages of B cell subset proportions in the indicated developmental are given  (+/- SEM). ND stands 
for ‘not detectable’. 
3.2.3 Competition of IgG1 and IgM during B cell development 
In order to assess whether IgG1 or IgM expression have an advantage during B cells 
development, we analyzed the mice heterozygous for IgG1i/WT associating with intact 
Igα/Igβ (IgG1i/WT), truncated Igα (IgG1i/WT;IgαΔc) or Igβ (IgG1i/WT;IgβΔc). Since the 
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surface expression of the BCR appears at the stage of BM immature B cells, we analyzed the 
expression of IgG1 or IgM only in this stage and also in peripheral B cells. 
In the periphery of the heterozygous IgG1i/WT mice with intact Igα/Igβ (IgG1i/WT), 
approximately 80% of peripheral B cells expressed IgM. This advantage of IgM expression is 
also observed in the heterozygous mice with truncated Igβ (IgG1i/WT;IgβΔc)(Fig.12). 
However, there are much fewer IgM B cells (9%) than IgG1 B cells (65%) in the 
heterozygous mice with truncated Igα (IgG1i/WT;IgαΔc)(Fig.12).  These results indicate and 
support our previous findings that forced Igα signaling (IgβΔc) induces IgM expression, 
whereas Igβ signaling (IgαΔc) preferentially polarizes peripheral B cells to an increased 
expression of IgG1. Hence, it is reasonable to investigate whether this distinct competition 
originates from immature B cell stage in the BM. 
In the BM of IgG1i/WT;IgβΔc as well as IgG1i/WT , the competition of IgG1 vs. IgM on 
immature B cells matched the peripheral result that IgM takes the advantage over IgG1 in 
those mice (Fig.12). Surprisingly, in contrast to the dominance of IgG1 usage in the 
periphery, IgG1i/WT;IgαΔc mice exhibit less IgG1
+ than IgM+ cells at the immature stage 
(Fig.12). Therefore, the increased γ1 expressing B cells in the IgG1i/WT;IgαΔc mice did not 
exist at the immature stage. We therefore wanted to investigate a potential increase in capacity 
for survival and proliferation in the periphery. 
 
 
Fig. 12 FACS analysis of competition of IgM+ and IgG1+ B cells in the heterozygous mice 
Splenic cells from indicated mice were gated on B220+ cells and checked for the surface markers IgM and IgG1. 
BM lymphocytes were gated on B220+AA4.1+ cells and check the surface marker of IgM and IgG1. 
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B220+AA4.1+Ig+ indicates immature B cells. B220+AA4.1-Ig+ indicates recirculating B cells. The numbers in the 
quadrants refer to the percentages of the specific cells population gated on live lymphocytes. 
3.3 IgG1 signal in supporting B cells survival and proliferation  
3.3.1 IgαΔc or IgβΔc B cells are sensitive to apoptosis 
Ten times more B cells were detected in mice with a combination of Igα mutation and 
IgG1 expression (IgαΔcIgG1i) compared to Igα mutant mice (IgαΔc). This relative 
enlargement of the mature B cell compartment might result from the increased signaling of 
IgαΔcIgG1i BCR in the periphery resulting in either sustained survival signals or increased 
proliferation.  
To investigate the survival capacities, B cells from the six indicated mouse strains were 
MACS purified or sorted and cultured in enriched medium and monitored for survival by 
FACS analysis using the dead cell marker 7AAD. As shown in the Fig.13A, after 72 hours of 
culture there are more viable WT, IgG1i and IgαΔcIgG1i B cells compared to the other three 
genotypes, which seems to resemble the B cell populations in the mice. However, it was 
noticed that B cells from IgαΔcIgG1i mice survived even better than B cells from WT whereas 
the ex vivo experiment showed a 10-fold decrease of B cell numbers in these mice compared 
to WT (Fig. 13A). 
BAFF, a member of the tumor necrosis factor (TNF) super-family, is known to signal 
through the BAFF receptor (BAFFR) and enhance B cell survival (Mecklenbrauker et al., 
2004; Schneider and Tschopp, 2003). To elucidate the contradicted phenotype of IgαΔcIgG1i 
in B cell survival, we cultured B cells in medium supplemented with BAFF. As seen in 
Fig.8A, more viable WT and IgG1i B cells were detected in the medium with BAFF than 
without BAFF. However, the numbers of the Igα or Igβ mutant B cells, regardless of 
immunoglobulin expression (IgαΔcIgG1i and IgβΔcIgG1i B cells), are not increased during 
culture with BAFF (Fig.13A). Interestingly, the viable B cell populations after culturing with 
BAFF strongly resemble the ex vivo peripheral B cell numbers shown previously (Fig.13A, 
Fig.8). Therefore, these data indicate that Igα or Igβ mutant B cells respond inefficiently to 
BAFF stimuli, thereby leading to the increased cell death compared to intact Igα/β−bearing B 
cells (WT or IgG1i). 
Furthermore, the surface levels of BAFF receptor were analyzed by FACS. In Fig.14B, 
we show that the Igα or Igβ mutant B cells expressed a much lower level of BAFFR on the 
surface compared to WT B cells, which explains the weak response of those B cells to the 
BAFF survival signal. 
Results 
 
56 
        
Fig. 13 Viabilities of periphery B cells in vitro and BAFFR surface level of BCR/ Igα/Igβ  mutant  
(A) Mature B cells were sorted based on CD19+CD23+ expression and then cultured in the absence or presence 
of BAFF (100ng/ml) for 72 hours. Viable cells were determined by 7AAD staining. Bars indicate the live cells 
proportion.  
(B) BAFFR surface level of B cells from BCR/ Igα/Igβ mutant mice 
 
The defect in the survival capacity of Igα or Igβ mutant B cells might be attributed to 
the down-regulation of anti-apoptotic genes. To investigate the mechanism underlying the 
defective survival of the Igα or Igβ mutant B cells, we performed quantitative real time PCR 
to evaluate the copies of mRNA transcripts from bcl2 and bcl2-like1, representing the proteins 
Bcl-2 and Bcl-XL, respectively. Both proteins play pivotal roles in anti-apoptotic regulation 
and processes of B cells survival.  
Indeed, Igα  or Igβ mutant B cells exhibited 5-10 fold decreased levels of gene 
transcription of Bcl-XL compared to WT B cells (Fig.14A). This reduction of Bcl-XL 
corresponds with the increased cell death of Igα  or Igβ mutant B cells compared to WT and 
IgG1i B cells. Moreover, transcript levels of Bcl-XL in IgαΔcIgG1i B cells were relatively 
higher than Igα mutant B cells (IgαΔc) whereas B cells from IgβΔcIgG1i display a decreased 
level of Bcl-XL compared to Igβ mutant B cells (IgβΔc) (Fig.14A).  These results are 
consistent with the viability in those B cells (Fig.13A) and suggest that the truncation of 
cytoplasmic tail of Igα or Igβ results in defective downstream expression of Bcl-XL, which 
consequently causes B cells to be sensitive to apoptosis. 
Interestingly, while Bcl-2 was significantly decreased in the Igβ mutant B cells (IgβΔc 
and IgβΔcIgG1i), it appears at an elevated level in the IgαΔc B cells (IgαΔc and IgαΔcIgG1i) 
compared to intact Igα/β B cells (WT and IgG1i) (Fig.14B). These results indicate a critical 
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role for Igβ signaling in regulating Bcl-2 expression. Furthermore, the fact that Igα mutation  
downregulated the transcript of Bcl-XL but not Bcl-2 suggests that distinct signals exist which 
regulate Bcl-2 and Bcl-XL separately in the inhibition of cell death.  
 
    
 
Fig. 14 Transcript level of Bcl-2 and Bcl-xl gene in the BCR/ Igα /Igβ  mutant mice 
Periphery B cells were sorted based on CD19+CD23+ and lysed for RNA according to the Trizol protocol.  
Bars indicate the live cells proportion. (A) Bcl-XL (B) Bcl-2  
3.3.2 Proliferation capacity of IgG1i, IgαΔcIgG1i and IgβΔcIgG1i B cells 
Since the truncations of Igα or Igβ result in decreased B cell compartments in vivo, it is 
of interest to make an inquiry as to whether Igα or Igβ mutation leads to hypoproliferation of 
B cells in response to stimulation or not. CFSE-labeled B cells were incubated with optimal 
concentrations of anti-IgM F(ab’)2 antibodies or were stimulated via toll like receptor (TLR) 
4. As seen in Fig.15, in medium there was no difference detected in the proliferative capacity 
among B cells from the indicated mouse strains. Moreover, B cells from Igα or Igβ mutant 
mice responded similarly to the B cell activator lipopolysaccharide (LPS). However, BCR 
induced proliferation in B cells from the IgαΔc, IgβΔc and IgβΔcIgG1i mice was drastically 
decreased compared to WT B cells. Approximately half of the live B cells from those mouse 
strains kept the high intensity of CFSE labeling and did not proliferate. In contrast, the 
proliferation of IgαΔcIgG1i B cells in response to BCR cross-linker is increased compared to 
WT B cells (Fig.15). These results postulated that the impaired signaling through Igα or Igβ 
ablated not only the survival but also the proliferation capacity of B cells, but the combination 
of IgG1 and Igα mutation (IgαΔcIgG1i) could replenish some of these survival signals. 
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Fig. 15 Proliferation of periphery B cells in vitro 
Peripheral B cells were labeled with CFSE. Cells were co-cultured in the absence or presence of anti-kappa 
(10µg/ml) plus IL4 (2ng/ml) for four days. The proliferation is evidenced by the loss of CFSE signal shown in 
the histogram. 
3.4 IgG1 derived BCR signaling 
3.4.1 IgG1 expression increases B cell activation in response to BCR engagement  
Calcium mobilization is an indicator of B cell activation and is also involved in BCR 
signaling (Kraus et al., 1999). The sustain time and strength of calcium flux could determine 
the NF-κB and NFAT signals, respectively (Dal Porto et al., 2004). We have measured the 
calcium mobilization of IgαΔc or IgβΔc B cells by kinetic analyses that define the change of 
calcium flux over time (Fig.16). B cells were enriched by negative depletion using MACS 
CD43 beads in order to get detectable density of B cells on the FACS and subsequently 
labeled with a calcium indicator, Fluo-3. After reaching 10,000 cells during a continuous 
acquisition, optimal concentrations of anti-kappa were injected into the acquisition tube.  
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As shown in Fig.16, BCR induced calcium flux of IgG1i B cells was observed to run 
in a similar kinetic compared to WT B cells. However, the calcium flux occurs over a shorter 
period in B cells with Igα mutation in combination with IgG1 BCR (IgαΔcIgG1i) compared to 
Igα mutant B cells (IgαΔc). In contrast, the B cells with Igβ mutation in combination with 
IgG1 (IgβΔcIgG1i) exhibit a prolonged calcium influx in response to BCR engagement than in 
the Igβ mutant B cells (IgβΔc). Actually, the calcium level in the IgβΔcIgG1i B cells had not 
returned to the initial level ten minutes after triggering (Fig.16). These data suggested that the 
signal of IgG1 shifted the calcium influx mainly in a time dependent manner, shortening it in 
the B cells with Igα mutation and extending it in the B cells with Igβ mutation. This diverse 
calcium mobilization indicates a distinct role of Igα and Igβ in transducing the signal of IgG1 
BCR-mediated calcium mobilization. Furthermore, the alteration of calcium flux implicated 
not only the abnormal upstream signal from B cell receptor but also the cascade changes on 
the downstream effectors. 
 
 
Fig. 16 Calcium flux response 
B cells were dyed with the calcium indicator Fluo-3. Calcium flux was measured in response to BCR cross- 
linking with 10µg/ml anti-kappa in splenic B cells gated based on CD23+ from IgαΔc, IgαΔcIgG1i, IgβΔc and 
IgβΔcIgG1i mice. Dot plots show the kinetics of Fluo-3 intensity (y axis) that indicates the calcium flux over 400 
seconds (x axis). 
3.4.2 BCR internalization and signaling of IgG1i, IgαΔcIgG1i and IgβΔcIgG1i B 
cells 
Altered BCR level is associated with changes of the BCR internalization in the Igα  
 or Igβ mutant mice (Gazumyan et al., 2006). We also assessed whether IgG1 expression 
affects the surface level of BCR. As shown in Fig. 17A, where the surface level of BCR of 
IgG1 B cells is lower than WT B cells, IgαΔcIgG1i or IgβΔcIgG1i B cells expressed BCR to a 
similar extent to IgαΔc or IgβΔc B cells. In addition, BCR levels of both IgαΔc and IgβΔc B cells 
were increased compared to WT (Fig. 17A). To determine whether these deviant cell surface 
levels of BCR in the IgαΔc or IgβΔc mice were associated with the altered BCR internalization, 
we measured the ligand induced internalization by treating B cells with (Fab’)2 anti-Ig 
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antibody for the indicated times (Fig. 17B). The BCR internalizations of each time point were 
judged by down-regulation of the fluorescence intensity in response to BCR engagement.  
Indeed, IgαΔc and IgβΔc B cells were severely impaired in BCR internalization compared
 
with WT B cells (Fig.17B). However, IgG1 expressing B cells (IgG1i, IgαΔcIgG1i or 
IgβΔcIgG1i) exhibit faster BCR endocytosis compared to WT B cells (Fig. 17B). Comparing 
these results with the respective BCR surface level, we observed that the slow internalization 
in the IgαΔc or IgβΔc B cells is consistent with their high surface level of BCR. However, the 
fast internalization in the IgαΔcIgG1i or IgβΔcIgG1i B cells is in contrast with their high BCR 
surface level. Therefore, other than altered BCR internalization, there might be some reasons 
remaining for the down-regulated surface levels of BCR in IgαΔcIgG1i or IgβΔcIgG1i B cells. 
Nonetheless, it is clear that whereas truncation of cytoplasmic tail of Igα or Igβ impaired non-
IgG1 BCR endocytosis, it did not influence IgG1 BCR endocytosis, which indicated that the 
cytoplasmic signal of Igα or Igβ is not required for IgG1 BCR internalization.   
 
                   
 
Fig. 17 BCR surface level and ligand induced internalization assay  
(A) Peripheral B cells were stained with CD19 and kappa antibodies. CD19+ B cells were gated to measure the 
BCR surface level shown in the histogram. 
(B) B cells were cultured with 10µg/ml bio-(Fab’)2 anti-IgM+IgG1 on ice or in 37°C for the indicated time. PFA 
was used to fix the cells and stop the reaction. Surface level was evaluated according to fluorescence intensity 
and the percentage of internalization was calculated based on the formula described in materials and methods. 
 
It was suggested that B cell receptor internalization is an important mechanism for 
attenuating BCR signaling (Brown and Song, 2001; Stoddart et al., 2005). Hence, we also 
investigated BCR signaling to clarify the interaction between BCR internalization and BCR 
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signaling of the BCR/Igα/Igβ mutant B cells. Because we cannot get a sufficient number of 
cells from the IgαΔc, IgβΔc and IgβΔcIgG1i mice to perform Western blot, we were only able to 
compare the BCR-triggered tyrosine phosphorylation among B cells from WT, IgG1 and 
IgαΔcIgG1i mice.  
In the first two minutes, WT and IgG1i B cells displayed a similar level of total 
phosphorylation (judged by anti-PY99 antibody). However, total phosphorylation in IgG1i B 
cells faded away faster than WT B cells (Fig.18A). The rapid and transient process of protein 
phosphorylation in IgG1i B cells was consistent with the fast internalization of the IgG1 BCR 
(Fig.17B). On the other hand, resulting from the absence of the cytoplasmic tail of Igα,  a 
reduced level of total phosphorylation was observed in the IgαΔcIgG1i B cells in response to 
BCR engagement compared to IgG1i B cells (Fig.14A).  
Phospholipase C gamma 2 (PLCγ2) relays information from the activated B cell 
receptor to downstream signal cascades by production of second-messenger, IP3 and DAG, 
which serve to activate Ca2+ mobilization (Kurosaki et al., 2000). The downstream effectors 
of PLCγ2 in the B cell receptor pathway include MAP Kinase and NF-κB transcript factors, 
which determine the signals for B cell proliferation and survival, respectively (Dal Porto et 
al., 2004).  
When paralleled with total phosphorylation, phosphorylation of PLCγ2 faded away 
more quickly in the IgG1i and IgαΔcIgG1i B cells compared to WT, which can explain the 
shortened period of calcium flux in those IgG1 cells (Fig.18B). On the other hand, only IgG1i 
B cells did not display an altered level of IKBα phosphorylation when compared to WT B 
cells, as we were able to show a weaker IKBα phosphorylation in IgαΔcIgG1i B cells (Fig. 
18B). Taken together with the reduced survival of IgαΔc and IgαΔcIgG1i B cells, these data 
indicated that Igα mutation might result in a lower level of activation in the NF-κB pathway 
and may consequently lead to a decreased transcription of Bcl-XL.  In contrast, in the MAP 
kinase pathway, WT, IgG1i and IgαΔcIgG1i B cells exhibited comparable kinetics in the 
phosphorylation of ERK. The unaltered ERK phosphorylation suggested that whereas an Igα 
mediated signal is critical for the NF-κB pathway, it is not required for the MAP kinase 
pathway. This divergent effect of an Igα-derived signal could strongly explain our previous 
observation that IgαΔcIgG1i B cells proliferate as well as IgG1i B cells but survive less 
adequately than IgG1i B cells.  
Interestingly, IgG1i B cells display a sustained phosphorylation of Lyn compared to WT 
B cells (Fig. 18C). Correlating with the notion that Lyn plays an essential role in negative 
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regulation of signaling (Xu et al., 2005), this sustained Lyn phosphorylation in the IgG1i B 
cells may account for its rapid PLCγ2 phosphorylation. 
             
           B 
 
           C 
 
 
     
 
Fig.18 Western blot analysis of BCR cross-linking induced protein phosphorylation  
Before prepared for protein, B cells were stimulated with anti-kappa antibody for the indicated time. The lysates 
were loaded for western blot and detected with indicated phosphorylation antibodies. β−actin antibody 
functioned as loading control. 
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3.5 IgG1 expression promotes the B cell maturation  
Immature B cells that passed negative selection circulate to the spleen and develop into 
mature B cells, marked by the loss of AA4.1 surface expression. We observed an increase in 
the mature B cell population (AA4.1-) in the IgG1i mice compared to WT mice (Fig.19A). 
This increased maturation was also detected in all the IgG1 expressing B cells in spite of Igα 
or Igβ mutation compared to the non-IgG1 B cells (IgG1i>WT, IgαΔcIgG1i>IgαΔc, IgβΔ
cIgG1i>IgβΔ c), which suggested that IgG1 expression promotes the differentiation of 
immature B cells into mature B cells  (Fig.19A).  
As a result of maturation, the majority of B cells enter the follicular regions (FO) in the 
spleen and LNs. In the IgG1i mice, we detected an increased marginal zone (MZ) 
compartment compared to WT mice. Likewise, Igα mutant mice in combination with IgG1i 
allele (IgαΔcIgG1i) exhibit an increased MZ fraction and elevated level of CD21 expression 
in the FO fraction compared to Igα mutant mice (IgαΔc). Moreover, an increased FO B cell 
compartment was also observed in the Igβ mutant mice in combination with the IgG1i allele 
(IgβΔcIgG1i) compared to the Igβ mutant mice (IgβΔc), though MZ cells are completely 
absent (Fig.19B). Taken together, these results indicate that IgG1 expression increases the B 
cell population entering the FO and MZ, which further supports the notion that IgG1 
enhanced the maturation of B cells (IgG1i, IgαΔcIgG1i and IgβΔcIgG1i) compared to non-
IgG1 B cells (WT, IgαΔc and IgβΔc) (Fig.19B) 
 
 
 
Fig. 19 FACS analysis of B cell subsets  
(A) Mature and immature B cells in the spleen of IgG1 expressing mice. Splenic cells were gated on CD19+ 
cells and stained with the indicated surface marker. CD19+AA4.1+ indicates transitional immature B cells. 
CD19+AA4.1- indicates mature B cells.  (B) FO and MZ in the spleen of IgG1 expressing mice 
CD19+CD21highCD23low indicates MZ B cells. CD19+CD21lowCD23high indicates FO B cells.  
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*The numbers refer to the percentages of the specific cells population gated on live lymphocytes. 
3.6 B-1 B cells in the peritoneal cavity of IgG1 expressing mice 
The surface antigen CD5 typically expressed on T cells is also found on B-lymphocytes 
called B-1 cells (Hardy and Hayakawa, 1986; Herzenberg et al., 1986). B-1 B cells mainly 
reside in the peritoneal cavity (PC) and differ from conventional B-2 B cells in a number of 
characteristics (Tarakhovsky, 1997). In particular, their ability to produce multi-reactive IgM, 
IgG3 and IgA in large amounts has led to the consideration that B-1 B cells might have some 
innate immune function (Hardy, 1992).  
As seen in Fig.20, we observed that the B-1 B cell fractions (CD19highCD5+) in the PC 
are distinctly reduced in IgG1i and IgβΔcIgG1i mice (5% and 10%) compared to WT and 
IgβΔc mice (57% and 31%) respectively. In contrast, B-1 B cells account for 48% of the PC B 
cells in mice with combined IgG1i and Igα mutation (IgαΔcIgG1i) whereas it displays only 
27% with Igα mutation (IgαΔc) (Fig.20). These results indicated that the B-1 B cell 
compartment is compromised with IgG1 alone or IgG1 in combination with the Igβ mutation, 
but not by IgG1 in combination with Igα mutation where the opposite tendency is observed. 
 
Fig. 20 FACS analysis of B cell compartment in the peritoneal cavity 
Lymphocytes were prepared from PC of the indicated mice. Cells were gated on CD19+ cells and stained with 
CD5. CD19+CD5+ cells indicate the B1 B cells. The numbers in the quadrants refer to the percentages of the 
specific cells population gated on live lymphocytes. 
3.7 Serum IgG1 level in the IgG1 expressing mice 
Sera immunoglobulins in the mice were evaluated in order to determine whether the 
IgG1 expression of B cells in the IgG1i, IgαΔcIgG1i and IgβΔcIgG1i mice contribute to basic 
antibody secretion. Determination of total IgM and IgG1 by ELISA showed that basal levels 
of immunoglobulin titers in the sera of the WT mice contained significantly higher IgM 
antibody titers compared to IgG1 expressing mice (Fig.21A). We also detected higher titers of 
IgG1 in the IgG1i mice compared to WT mice (Fig.21B). These are the consequence of the 
mutation that constant region of µH was replaced by γ1H in the IgG1i mice. In addition, there 
are hardly any IgG1 antibodies detectable in the serum of IgαΔc, IgβΔc and IgβΔcIgGi mice, 
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which mirrors the small amount of B cells in those mice (Fig.21B). However, despite the ten 
fold decreased B cell numbers, IgαΔcIgG1i mice surprisingly exhibited an increased level of 
serum IgG1 compared to WT mice (Fig.21B).  
The source of basal serum immunoglobulin could be plasma cells and B-1 B cells, the 
natural Ig secreting cells (Hayakawa et al., 2000). To assess whether the elevated serum IgG1 
from IgαΔcIgG1i mice results from increased numbers of IgG1 expressing plasma cells or B-1 
B cells, we prepared cytospin slides of BM cells and stained them with anti-IgG1 antibody to 
count the plasma cells as plasma cells usually reside in the BM. Counting results show us 
approximately ten times less plasma cells in the IgαΔcIgG1i mice than in the WT mice, which 
is correlated with their total B cells number. These data indicate that plasma cells were not the 
source of the increased titers of serum IgG1 in the IgαΔcIgG1i mice. This enhanced titer of 
IgG1 must result from the increased amount of auto-secreting B-1 B cells. 
 
 
Fig. 21 Serum IgG1 level in the BCR/ Igα /Igβ  mutant mice 
Sera were prepared as described from indicated mice. Titers of antibodies were evaluated by ELISA.  
3.8 IgG1 B cells in Igα /Igβ  double mutant mice 
As the γ1 insertion increased the B cell compartment in the Igα mutant mice (IgαΔ
cIgG1i) but not in the Igβ mutant mice (IgβΔ cIgG1i), it could be conceived that the 
combination of γ1 and Igα mutation rather than γ1 alone caused the increased B cell 
compartment. Subsequently, we assessed whether this combination could also contribute to 
the B cells compartment in the IgβΔc mice.  
We generated IgαΔcIgβΔcIgG1i mice, in which IgG1 BCR is associated with cytoplamic 
tail-truncated Igα/Igβ (Fig.7). All the IgαΔ cIgβΔ cIgG1i mice did not demonstrate any 
differences in survival capacity compared to WT mice. However, our data show no detectable 
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B cells in the IgαΔcIgβΔcIgG1i mice, neither in the lymph nodes nor in the spleen (Fig.22A, 
B). We could not detect any B cells in the peritoneal cavity either (Fig. 22C). This suggests a 
very severe block exists during BM B cell development in these mice. 
Indeed, in the BM of IgαΔcIgβΔcIgG1i mice there were only pro-B cells (B220+CD43+) 
and no immature and recirculation B cells (B220+Ig+) detectable (Fig. 22D). Analysis of pre-
B cells (B220+CD25+) ensured that B cells development of IgαΔcIgβΔcIgG1i mice cannot 
proceed beyond pre-B cells stage (Fig.22D).  Similar to the published data of mice with the 
double truncation of Igα and Igβ,  γ1 expression in combination with double mutation of Igα 
and Igβ (IgαΔcIgβΔcIgG1i) results in a complete developmental arrest preceding the pre-B 
cell stage. 
 
 
 
 
Fig. 22 FACS analysis of B cell development in the 
BM of IgG1i/mutant mice 
(A) Lymphocytes from lymph nodes were gated on 
CD19+ cells and stained with the surface marker of 
AA4.1. CD19+ AA4.1- indicates mature B cells. 
CD19+AA4.1+ indicates immature B cells.  
(B) Splenic cells were gated on CD19+ cells and 
stained with the surface marker of CD21 and CD23. 
CD19+CD21highCD23low  indicates marginal zone B 
cells.  
(C) Lymphocytes were prepared from peritoneal cavity 
of the indicated mice. Cells were gated on CD19+ cells 
and stained with CD5. CD19+CD5+ indicates the B1 B 
cells. CD19+CD5- indicates the B2 B cells. 
(D) BM lymphocytes were prepared from the indicated 
mice. Cells were gated on B220+ cells and stained with 
pro B cells marker CD43 and Ig surface marker. 
B220+Ig-CD43+ cells are pro-B cells. B220+Iglow cells 
are immature B cells and B220+Ighi are recirculation 
mature B cells. B220+CD25+ are pre-B cells.  
*The numbers in the quadrants or gates refer to the 
percentages of the specific cell population, gated on 
live lymphocytes. 
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3.9 Deficiency of Smad7 in B cells enhanced IgA class switch 
 
Smad7 expression is induced by signaling of TGF-β superfamily members. After 
induction, Smad7 negatively regulates TGF-β signaling by two distinct mechanisms. While 
TGF-β receptor I (ALK5) is critical for TGF-β signal transduction, Smad7 can directly 
compete with Smad2 and Smad3 for ALK5 binding or can degrade ALK5 through 
recruitment of Smurf-containing E3 ubiquitin ligase complexes. 
3.9.1 Generation of Smad7FL/FL mice 
To investigate the physiological role of Smad7 we have generated a conditional Smad7 
knockout mouse model (Smad7flox). By using this model we are able to check the function of 
Smad7 in specific tissues and development stages (Fig.23).  
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Fig. 23 Generation of Smad7FL/FL and Smad7del mice 
The scheme represents the targeting strategy. (Kindly provided by Ingo Kleiter) The targeting vector was 
constructed based on pRAPIDflirt (a). The structure of the Smad7 gene from exon 1 to exon 3 is shown on the 
top (b). Homologous recombination into the Smad7 gene resulted in the neor containing genotype  (Smad7neo)(c). 
The following genotypes Smad7FL and  Smad7del have been generated through Flp- (d) and Cre- (e) mediated 
recombination (see methods). 
3.9.2 Generation of CD19Cre Smad7FL/FL mice 
TGF-β receptor II is required for the initial binding of TGF-β. The absence of TGF-β 
receptor II in B cells leads to a reduced life span of conventional B cells, expansion of 
peritoneal B-1 cells and elevated serum immunoglobulin with the exception of IgA (Cazac 
and Roes, 2000). In order to assess whether deficiency of Smad7 in B cells results in the 
opposite phenotype, we generated the CD19Cre/Smad7flox mice, in which the deletion of 
Smad7 takes place solely in B cells. 
To generate mice with B cell specific deletion of Smad7, Smad7flox mice were 
intercrossed with the CD19-Cre mouse strain The CD19-Cre mouse has been shown to delete 
loxP flanked alleles specifically in the B cell lineage (Rickert et al., 1997). The deletion 
efficiency was shown to be 75- 80% in the BM and over 95% in splenic B cells (Inui et al., 
2002) (Cazac and Roes, 2000; Rickert et al., 1997).  
To evaluate the efficiency of Smad7 deletion in the CD19Cre/Smad7flox mice, we 
analyzed the gene transcript of Smad7 in B and T cells by real time PCR. Compared to the 
WT control, transcript of Smad7 in B cells from CD19Cre/Smad7flox mice was 20-fold 
decreased, whereas its expression level remained unchanged in a control T cell population 
(Fig.24).  
 
               
Fig. 24 Identification of specific deletion in the B cells of CD19Cre/Smad7flox (Smad7-B) mice 
Total RNA was isolated from the B cells of WT and CD19Cre/Smad7flox mice. Using these RNAs as templates, 
cDNA was synthesized according to the Invitrogen protocol and real time PCR was performed with the Smad7 
specific primers from Qiagen. 
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3.9.3 B cell homeostasis in the BM and Spleen of CD19Cre Smad7FL/FL mice 
Former data demonstrate that TGF-β inhibits proliferation of B lymphocyte progenitors 
and also induces apoptosis in B lymphocyte progenitors, immature B cells and resting B cells 
(Lomo et al., 1995) (Kee et al., 2001). However, the inactivation of TGF-β-inhibitor Smad7 
did not affect B cell development in the bone marrow, as indicated by normal frequencies of 
pre-B, immature B, and mature B cells (Fig. 25A). Also, normal proportion of immature, 
mature, FO and MZ B cells in the spleen indicated efficient B cell generation and 
establishment of the peripheral B cell pool (Fig. 25B). 
 
          
 
Fig. 25 B cell homeostasis in the BM and Spleen of CD19Cre Smad7FL/FL mice 
(A) Percentage of B cells of indicated developmental stages in the bone marrow of CD19Cre/Smad7flox mice 
(B) Percentage of indicated subsets of lymphocytes in the spleen of CD19Cre/Smad7flox mice 
 
In the PC, we detected a 2-fold decrease of B-2 B cells in the Smad7 mutant mice 
compared to controls, which is shown by the cell proportions (Fig.26A and B). Nevertheless, 
we did not observed any decrease of B cell population in the spleen and LN. 
         
 
Fig. 26 FACS analysis of B cell populations in the PC 
(A) Lymphocytes were prepared from peritoneal cavity of the indicated mice. Cells were gated on CD19+ cells 
and stained with CD5. CD19+CD5+ cells indicate the B1 B cells. The numbers in the quadrants refer to the 
percentages of the specific cell population, gated on live lymphocytes. 
(B) Bar graph shows the percentage of B-1 and B-2 B cells in the total PC cells. 
Results 
 
70 
To assess whether this decrease is attributed to defective survival of the B cells in the 
Smad7 mutant mice, we cultured B cells from Smad7 deficient or control mice in the presence 
or absence of TGF-β for three days and monitored the viable cell percentage by 7AAD 
staining. Consistent with the decrease of PC B-2 cells, the Smad7 deficient B cells died much 
faster compared to control cells when treated with or without TGF-β  (Fig.27). These in vitro 
data suggested that the decrease of B-2 B cell populations in the Smad7 deficient B cells 
results from the increased B cell apoptosis.  
 
Fig. 27 Viabilities of peripheral B cells in vitro and BAFFR surface level of BCR/ Igα/Igβ  mutant   
Mature B cells were cultured in the absence or presence of TGF-β (10ng/ml) for 3 days. Viable cells were 
determined by 7AAD staining. Bars indicate the live cells proportion. 
3.9.4 Smad7 mediates TGF-β-controlled class switch 
TGF-beta signaling is known to direct the class switch toward IgA (Klein et al., 2006). 
B cell specific Smad7-deficient mice exhibit a clear enhancement in IgA production in the 
total serum level, consistent with the previously published data. On the other hand, the titer 
level of serum IgG1 was reduced in the Smad7 mutant mice (Fig. 28).  
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Fig. 28 Serum IgA level in the CD19Cre/Smad7flox mice 
Serum IgA (A) and IgG1 (B) level were evaluated with ELISA. Bar graph shows the titers of serum Ig from 
indicated mice. 
 
To investigate whether the enhanced serum IgA of Smad7 deficient mice results from an 
increase in IgA class switch, we dissected B cell population in the Peyer's patches (PP). PP is 
one of the gut-associated lymphoid tissues. The activated or switched status of B cells in this 
compartment is reflected in the numbers of B cells engaged in germinal center reactions, as 
indicated by their positive staining for peanut agglutinin. Increased numbers of germinal 
center B cells were observed in CD19Cre/Smad7flox mice compared to WT mice (Fig.29).  
Accordingly, we detected a 3-fold increase of IgA+ B cells in the PP of Smad7 mutant mice 
compared to controls (Fig.29). Since majority of the switched B cells are located in the 
germinal center, the increase of IgA cells may account for the enlargement of the germinal 
center in the Smad7 mutant mice. In addition, a reduced population of IgG1+ B cells was 
observed in the mutant mice (Fig.29), which is consistent with the decreased titer of total 
serum IgG1 (Fig.29). These results indicate that the enhanced serum IgA and reduced serum 
IgG1 in Smad7 mutant mice results from the increase in class switch to IgA and the decrease 
in class switch to IgG1. 
 
 
 
Fig. 29 FACS analysis of Peyer's patch 
lymphocytes of control and Smad7 deficient mice 
(A) Fas and PNA staining of Peyer's patch 
leukocytes.  
(B) CD19 and IgA staining identifies IgA+ B cells in 
the Peyer's patch.  
(C) CD19 and IgG1 staining identifies IgG1+ B cells 
in the Peyer's patch.  
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To assess whether the class switch of increased IgA and decreased IgG1 was due to the 
altered B cell response to TGF-β  in the Smad7 mutant mice, we determined IgA expression at 
the cellular level by inducing class switch in vitro. In LPS/TGF-β cultures, the frequency of 
IgA+ Smad7 mutant B cells increased to 7.2%, whereas IgA class switching in the control B 
cell cultures increased to 5.5% (Fig.30A). On the other hand, in either LPS/IL4 or 
LPS/IL4/TGF-β cultures, Smad7 mutant B cells exhibited a two-fold reduction in IgG1-
directed class switch compared to controls (Fig.30B). This in vitro class switch implied that 
the altered titers of serum antibodies in Smad7- deficient mice result from derangement of 
TFG-beta signaling in B cells.  
 
 
 
Fig. 30. IgA class switching in splenic B cell 
cultures  
CD43-depleted spleen cells from control and Smad7 
mutant mice were cultured as indicated for 4 days. 
Shown is the percentage of IgA+ (A) or IgG1+(B) 
cells. 
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3.10 Targeting NIK gene by BAC strategy 
In the non-canonical NF-кB pathway, stimulation of receptors belonging to the TNFR 
super-family leads to the recruitment of TRAF proteins like TRAF2, TRAF3 and TRAF6 
which activates the protein kinase NIK through a currently unknown mechanism. NIK then 
selectively phosphorylates and activates the IKKα catalytic subunit. This pathway is 
important for secondary lymphoid organogenesis, maturation of B cells, adaptive humoral 
immunity and optimal promotion of cell survival (Zarnegar et al., 2004). 
Although abnormalities in both lymphoid tissue development and antibody responses 
were shown in both aly mice and NIK–/– mice (Garceau et al., 2000; Yin et al., 2001), the 
importance of NIK are not clear in the specific cellular lineage and development stage. To 
identify the physiological functions of NIK, we conditionally targeted the NIK locus. 
Interaction of NIK in different cell lineages can then be studied by crossing the NIKflox mice 
with specific Cre mice. 
3.10.1 Gene targeting of NIK  
The NIK gene consists of 14 exons. Exon 2 harbors an ATP binding site. Upon Cre-
mediated recombination, excision of exon2 should result in an out-of-frame transcript of NIK. 
Therefore, we decided to flank exon2 with loxP sites in order to ablate the gene transcript of 
NIK. Standard gene targeting techniques were employed to generate NIKFL/FL mice using the 
strategy shown in Fig.31. To insert the loxP sites flanking exon2, the conventional targeting 
vector was generated by inserting the short arm of homology (SA), exon2 (FA), and the long 
arm of homology (LA) into the pRAPIDflirt vector (A. Bruehl and A. Waisman; unpublished 
data). The pRAPIDflirt vector already contained the loxP sites, the FRT flanked neomycin 
resistance gene and the thymidine kinase (TK) gene from Herpes simplex as a negative 
selection marker. 
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Fig. 31 Schematic representation of the NIK targeting strategy 
The structure of the NIK gene from exon 1 to exon 6 is shown on top row. Homologous recombination into the 
NIK gene resulted in the neor containing genotype  (NIK neo) (Kindly provided by Max v. Hollen). The following 
step will be Flp- and Cre- mediated gene recombination (see methods). The closed triangles represent loxP sites, 
the closed ovals FRT sites. Arrows indicate transcriptional orientations of genes. 
 
This project was done by Max von Holleben. The efficiency of targeting ES cells was 
very low and the injection of positive clones has so far failed to give rise to chimeric mice. 
Therefore, we decided to use BAC strategy. BAC targeting works very efficiently because it 
can provide long homologous recombination arms and avoid mutation derived from unfaithful 
PCR amplification (Fig.32). In order to modify the BAC, we adopted a novel cassette, in 
which the kanamycin/neomycin resistance cassette and the neo resistance gene are under the 
control of a prokaryotic and a eukaryotic promoter, respectively. After insertion of neo 
cassette into pGEM-T-easy vector by TA cloning, the short arm with one loxp site was 
amplified from former target vector and inserted with Aat II and Sac I. Finally, the construct 
was finished by cloning the Exon2 with the other loxp site into Asc I cutting sites. Using this 
construct as template, we amplified a PCR product including all the inserts from this construct 
and co-transfected it with the pRed/ET into NIKBAC (Fig.32). 
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Fig. 32 Targeting of the Neo-flox Construct into the NIK BAC 
(A) The short arm with one loxp site, the neo cassette and exon2 loxp region were cloned into pGEM-T-easy 
vector. 
(B) The PCR product including neo and loxp sites was recombined into the NIK locus on the BAC by Red/ET 
cloning. The procedure is described in the methods. 
3.10.2 Generation of the Modified NIKBAC  
To ensure the homology arms and loxp region are free of mutations, they were 
sequenced by use of the primers for the 5’ end and for the 3’ end of the exon2. Since the Neo-
frt cassette was PCR amplified, it was also sequenced. No mutations were detected. 
The PCR product was introduced into E. coli cells carrying the NIK BAC and the 
Red/ET recombination plasmid pSC101-BAD-gbaA-tetra. Expression of the recombinases 
was induced by administration of L-Arabinose on 37°C. Recombination between the PCR 
product and the NIK gene on the BAC results in a BAC with a modified NIK gene, as shown 
in Fig. 33. E. coli cells were screened for the recombination event by selection with 
chloramphenicol to screen for the presence of the BAC and kanamycin to screen for the 
integration of the PCR product. 
Surviving colonies had to be further characterized for proper integration of the Neo-loxP 
construct in the NIK locus. A Southern blot strategy was designed to screen the HindIII 
digested targeted BAC DNA. BAC DNA was prepared and digested with HindIII and after 
Southern blotting screened with the 5’ probe SA and the 3’ probe LA (Fig.33). We expected a 
wild-type band of 14 kb and a targeted band of 10 kb with the 5’ probe, a wild-type band of 
6,1 kb and a targeted band of 4,7 kb with the 3’ probe (see also Figure 31). 
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                                                             5’ probe                 3’ probe 
Fig.33 Analysis of the Targeted NIK BAC with  Southern Blot  
HindIII digested DNA was transferred onto a nylon membrane and screened with the 32P-radiolabeled 5’ probe 
and 3’ probe and evaluated by phosphoimaging. Digested DNA of a wild type NIK BAC was run as a control 
(upper bands). Arrows indicate modified BAC Clones. 
3.10.3 Generation of the ES Cell Line NIKflox 
200 ml of modified BAC were grown overnight and DNA was prepared as described in 
methods. Roughly 100 µg of linear DNA were used per transfection. The DNA was linearized 
with the endonuclease PI-SceI, an enzyme that cuts in the BAC backbone. The transfected 
cells were plated on ten gelatinized feeder covered 10 cm plates. ES cells were screened for 
Neo integration by positive selection with G418. 40 surviving colonies were picked. 
Screening for homologous recombinants was performed with Southern blot after HindIII 
digest of the ES cell derived genomic DNA (Fig.34). 
 
 
Fig. 34 Analysis of the Targeted NIK ES cell clones with Southern Blot  
Southern blot analysis of HindIII digested ES cell DNA using the 32P-radiolabeled 3’ probe to screen 
homologous recombinants. 
 
It is difficult to screen for homologous recombinants by Southern blot since designing 
external probes is impossible due to the size of the BAC. Therefore we had to optimize and 
quantify the signal of the targeted and the wt band. The homologous recombinants should 
have equal density of these two bands (Fig.34).  
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Fig. 34 Reanalysis and quantification of the targeted NIK ES cell clones with Southern Blot  
Genomic DNA from confluent wells (96 well plate) of cells was digested with HindIII. In order to confirm 
homologous recombinants we performed southern blot analysis using 3’ probe to quantify the intensity of WT 
band and targeted band, in which DNA from WT clones were loaded as control, 
 
Random integration normally leads to insertion of the backbone into random locus. To 
exclude the double random integration that could also give rise to equal intensity of southern 
blot bands, a PCR strategy was designed to detect the backbone in which the DNA from 
promising clones was used as templates (Fig.35). Such a concept was used to adopt TK or 
DTA as negative selection gene in the traditional strategy (Yu et al., 2000). Two pairs of PCR 
primers were optimized by using obvious random integration as positive control. Each of 
them locates on the end of backbone of BAC. 
 
 
Fig. 35 BAC backbone PCR to detect random integration  
DNA from promising candidates of southern blot analysis was used as templates. PCR was done with two pairs 
of primers that located on the both end of the BAC backbone. Arrows indicate the homologous recombination 
clones. 
 
The procedure from injection to homozygous mice is time-consuming. Thus FISH 
(Fluorescence in situ hybrid) was performed to confirm the copies of NIK gene inside the 
clone with equal density of WT and targeted band in the quantitative Southern blot and 
negative in the PCR for detecting random integration. As shown in Fig.36 only two copies of 
NIK gene were observed which located in the end of chromosome11. The result ensured that 
the quantitative southern blot and the PCR detecting random integration was efficient tool to 
select homologous recombination clones. 
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Fig. 36 FISH analysis of copies of NIK 
FISH was performed to identify the copies, location 
of the allele of interest and the number of 
chromosomes. Red points indicate binding of the 
NIK-specific probe. 
 
 
 
 
 
 
 
 
 
To evaluate the function of loxP induced deletion, in vitro deletion of the loxP flanked 
exon 2 and the neomycin resistance gene by Cre-mediated recombination were performed on 
the recombinant clones (Fig.37). Cre activity was achieved by transducing with various 
amounts of a soluble and cell permeable Cre (Peitz et al., 2002). 
 
 
Fig. 37 In vitro Cre induced gene recombination 
Homologous recombinant clones were treated with indicated concentrations of a cell permeable Cre (HTNC). 
PCR was performed with the primers binding outside of the loxP region. 
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4 DISCUSSION 
4.1 IgG1 B cell receptors play distinct roles when in combination 
with Igα /Igβ  mutation  
IgG1 (γ1), known as a surface marker of memory B cells, is characterized by a 
conserved cytoplasmic tail that is lacking in IgM (µ) and IgD (δ) chains (Geisberger et al., 
2003; Neuberger et al., 1989; Reth, 1994). To investigate the physiological role of this 
cytoplasmic tail, a novel mouse strain (IgG1i) was established in which Cγ1 replaces all the 
other CH gene segments. IgG1i mice exclusively express membrane-bound IgG1 in the B 
lineage. Two major advantages exist in this mouse model compared to previous systems. 
Firstly, the known limitations involved in using transgenic expression of B cell receptors, 
namely uncontrolled copy number and position-dependent variations of expression, can be 
circumvented.  Secondly, IgH expression is controlled by the very same VH promoters which 
are used in normal B cell development. In these mice, we observed that B cells of all subsets 
are generated and the overall size of the peripheral B cell compartment is similar to the one 
for WT mice. However, B cell development in the BM of IgG1i mice is clearly compromised, 
with a partial developmental block at the pro– to pre–B cell transition. 
Furthermore, it is known that signal transduction through µ and δ chains relies entirely 
on the cytoplasmic tails of the BCR-associated Igα/β heterodimer. It was of interest to 
investigate whether signal-transduction through γ1 is also Igα/β-dependent. Thus, we 
generated the IgαΔcIgG1i mice, which carry the IgG1 BCR in combination with Igα 
truncation and the IgβΔcIgG1i mice, which carry the IgG1 BCR in combination with Igβ 
truncation. Similar to previous reports from Igα or Igβ  truncated BCR, the transition from 
immature to mature B cells is strikingly reduced in both IgαΔcIgG1i and IgβΔcIgG1i mice, 
with most immature B cells undergoing apoptotic cell death. However, signaling through γ1 
affects the peripheral B cell compartment distinctly when combining Igβ truncation or Igα 
truncation. B cell numbers in IgαΔcIgG1i mice is over ten times the number in IgαΔc mice. In 
contrast, IgβΔcIgG1i mice did not increase the number of B cells when compared with IgβΔc 
mice. There are two possibilities that account for the increased number of B cells in the 
IgαΔcIgG1i mice. One is that the combination of IgG1 with Igβ truncation ablates the B cell 
development more severely than with Igα□truncation, which could reduce of the number of 
progenitors that migrate from the BM to differentiate into mature B cells in the spleen. The 
other possibility could be that a signal through IgG1-linked Igα (IgβΔcIgG1i) is less capable of 
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supporting peripheral B cell survival or proliferation compared to the signal through Igβ 
(IgαΔcIgG1i). 
Compared to the BM B cell development of non-IgG1 expression mice (WT, IgαΔc and 
IgβΔc), we observed an accumulated pro-B cell population and a reduced pre-B cell population 
in the IgG1 expressing mice (IgG1i, IgαΔcIgG1i and IgβΔcIgG1i). This indicates that γ1 
expression results in an impaired transition from pro- to pre-B cells. In pre-BCR-deficient 
mice, B cell development is largely blocked at the pro- to pre- B cell transition, during which 
the cells go through a pre-BCR dependent phase of rapid proliferation (Martensson et al., 
2002). This reveals that pre-BCR plays a crucial role at the transition from pro- to pre- B cells 
in development. Although a developmental block was observed at the same stage of the IgG1i 
mice, it is clearly much milder than pre-BCR-deficient mice in that many more pre-B cells 
were detected. We therefore speculate that a γ1 chain-containing pre-BCR-like molecular 
complex is assembled in the IgG1i mice but it is functionally compromised. On the other 
hand, immature B cell numbers from IgG1 and non-IgG1 expressing mice are comparable. 
IgαΔcIgG1i mice contained a similar amount of immature B cells to IgαΔc, which disproved 
the possibility that the increased number of B cells in IgαΔcIgG1i mice stems from its 
advantage in BM B cell development. Nonetheless, considering the developmental 
impairment in the pre-B stage of IgG1 expressing mice, their WT-comparable immature B 
cell population suggested that rather than pre-BCR, BCR are more compatible with the 
signals through IgG1.  
In line with the decreased number of pre-B cells, the IgG1 expressing cells compete 
poorly in development with their WT counterparts in heterozygous IgG1i and IgG1iIgβΔC 
mice. This effect is more dramatic at the level of immature B cells in the BM than that of 
mature splenic B cells. On the other hand, in consistent with the increased number of B cells 
in the IgαΔcIgG1i compared to IgαΔc mice, the dominant population of IgG1
+ cells were 
detected in the IgαΔc;IgG1i/WT heterozygous mice. However, this advantage of IgG1 
expression did not exist in immature B cells in the BM. These data further support that the 
survival or proliferation factors in the periphery other than BM development account for the 
increased peripheral B cells in the IgαΔcIgG1i mice compared to IgαΔc mice.  
4.1.1 γ1 signals support the B cells survival  
The survival of mature resting B cells in the periphery depends on signaling from the B-
cell receptor (BCR) and the B-cell activating factor of the TNF family receptor (BAFF-R) 
(Mecklenbrauker et al., 2004; Schneider and Tschopp, 2003). Our in vitro data show that all 
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of Igα and Igβ mutant B cells except for the IgαΔcIgG1i B cells survive less adequately 
compared to WT and IgG1i B cells. However, when those B cells were cultured with medium 
with supplementary BAFF, Igα or Igβ mutant B cells, including IgαΔcIgG1i B cells, survive 
much less compared to WT B cells, indicating those cells hardly react to BAFF. Furthermore, 
The decreased expression level of BAFFR is associated with the reduced BAFF response in 
the Igα and Igβ mutant B cells. This down-regulation of BAFF-R could explain the impaired 
survival capacity in those B cells, which was previously reported in the mouse model lack of 
the RhoGTPases Rac1 and Rac2 (Walmsley et al., 2003). 
Although signals through either the BCR or BAFF-R are individually capable of 
promoting B-cell survival, the simultaneous stimulation of both pathways has a synergistic 
effect on proliferation and maintenance (Rolink et al., 2002). This is evidenced by a previous 
study showing that BAFF-R expression is up-regulated in response to IgM stimulation in 
mature B cells (Patke et al., 2004). One mechanism to account for this could be the sequential 
induction of one pathway by the other in a positive feedback loop. As BAFF-R expression is 
induced by BCR signaling, it is conceivable that disruption of BCR would impair BAFF-R 
expression. Thus, the insufficient expression of BAFF receptor could be a consequence of the 
mutation of Igα or Igβ and subsequently results in the inability of B cells to respond to BAFF 
survival signals.  
The anti-apoptotic Bcl-2 family proteins Bcl-2 and Bcl-XL play important roles in 
inhibiting mitochondria-dependent extrinsic and intrinsic cell death pathways. In our data, 
consistent with the increased cell death, Bcl-XL expression is down-regulated in both Igα or 
Igβ truncated B cells compared to WT B cells. It was observed that NF-κB activation and 
expression of Bcl-XL were severely blocked in both PIK3 and Btk deficient mice. Transgenic 
expression of Bcl-XL restored the B cell compartment in the PIK3 deficient mice (Suzuki et 
al., 2003). Therefore, the truncation of Igα or Igβ might impair the signal through PIK3 and 
Btk, thereby leading to down-regulated Bcl-XL expression. On the other hand, whereas Bcl-2 
expression is dramatically down regulated in the Igβ-truncated B cells, Igα-truncated B cells 
exhibit a similar level of Bcl-2 expression compared to WT B cells. The difference in the Bcl-
2 expression level between Igα and Igβ truncated B cells shows that the signal through Igβ 
rather than Igα is essential for the expression of Bcl-2. Also, these data addressed that the 
distinct signals regulate Bcl-2 and Bcl-XL in the inhibition of cell death, which was observed 
in a previous study showing that Bcr-Abl induced a dramatic down–regulation of Bcl-2 and 
increased the levels of Bcl-XL in HL-60 cells (Amarante-Mendes et al., 1998).  
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4.1.2 γ1 signals in the BCR signaling 
Compared to WT B cells, BCR expression levels on Igα or Igβ truncated B cells are 
enhanced while IgG1i B cells exhibit a decreased expression. An enhanced BCR level was 
reported to be attributable to a decrease in the BCR internalization (Gazumyan et al., 2006). 
In line with the increased BCR levels, either IgαΔc or IgβΔc BCR internalized slower than WT 
BCR. Nonetheless, both IgαΔcIgG1i and IgβΔcIgG1i BCR showed a similar kinetic of 
internalization when compared to IgG1i BCR, which was in contrast to their enhanced surface 
levels. Therefore, other than altered BCR internalization, there might be some reasons 
remaining for the down-regulated surface levels of BCR in IgαΔcIgG1i or IgβΔcIgG1i B cells.  
Experiments with inhibitors of tyrosine kinases and phosphotases have implicated 
ligand-induced tyrosine phosphorylation in regulating BCR internalization (Pure and Tardelli, 
1992; Salamero et al., 1995). On the other hand, blocking BCR endocytosis with 
pharmacologic agents or by deletion of the clathrin heavy chain in chicken B cell lines leads 
to enhanced signaling, suggesting that receptor internalization is an important mechanism for 
attenuating BCR signaling (Brown and Song, 2001; Stoddart et al., 2005). Supporting the 
interaction between BCR internalization and the subsequent dynamic changes of 
phosphorylation, our data showed that BCR induced general tyrosine phosphorylation 
disappeared faster in the IgG1 expressing B cells than in the WT B cells, which is consistent 
with the fast ligand-mediated internalization of BCR on these cells. Paralleled with general 
phosphorylation, phosphorylation of PLCγ2 faded away more rapidly in the IgG1i and 
IgαΔcIgG1i B cells compared to WT B cells. As PLCγ2 is the molecule responsible for the 
activation of BCR mediated calcium mobilization (Alberola-Ila et al., 1997), we have 
observed the shortened process of calcium flux in those IgG1 cells. Due to the small number 
of B cells, we do not have the data of PLCγ2 phosphorylation of IgβΔcIgG1i B cells. Thus it is 
hard to explain the prolonged calcium flux in IgβΔcIgG1i cells while BCR internalization in 
these cells was as fast as in IgG1i B cells. However, it is clear that one of the calcium release 
pathways is ablated in the BCR signaling mediated by IgG1 in absence of Igβ. 
 Calcium influx can regulate a large number of downstream molecules including 
transcription factors such as NF-κB and NFAT in lymphocytes (Antony et al., 2003). 
However, while the magnitude of the calcium response controls NF-κB activity, it is the 
duration of elevated Calcium influx that influences NF-AT activation (Dolmetsch et al., 
1997). Since the dynamic changes of calcium in IgαΔcIgG1i and IgβΔcIgG1i B cells is time-
dependent, it would be interesting to analyze the signaling of NFAT pathway in the future. 
PLCγ2 activity and the subsequent generation of IP3 and DAG potentially influence the 
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MAP Kinase and NF-κB pathway, which determine the signals of B cell proliferation and 
survival, respectively (Patterson et al., 2005). We have observed a distinct role of PLCγ2 in 
the promotion of MAP Kinase and NF-κB pathways. Whereas IgαΔcIgG1i B cells share a 
similar kinetic of ERK phosphorylation with IgG1i B cells, a weaker IΚBα phosphorylation 
was detected in the IgαΔcIgG1i B cells compared to IgG1i B cells. This result suggests that 
Igα is critical for the signal transduction of IgG1 BCR by regulating PLCγ2 phosphorylation 
and subsequently the activation of NF-κB pathway, which could account for the altered 
expression of basal Bcl-XL. However, MAP Kinase ERK is not directly influenced by IgG1 
BCR mediated PLCγ2 phosphorylation. This might explain that no apparent ablation was 
observed in the proliferation of the IgαΔcIgG1i B cells. 
Lyn, one of the Src-family kinases, was assigned a role in signal initiation from BCR 
(Gauld and Cambier, 2004). Interestingly, phosphorylation of Lyn shows distinct kinetics in 
the WT and IgG1 B cells in which Lyn was phosphorylated more slowly in the IgG1 B cells 
than in the WT B cells. Hence, it is reasonable to conceive that unlike WT BCR, activation of 
IgG1 BCR induced a sustained phosphorylation of Lyn, which subsequently regulated the 
downstream signal transduction such as PLCγ2, which exhibited a quickly diminished 
phosphorylation. This correlated with the notion that Lyn can also play an essential role in 
negative regulation of signaling through its unique ability to phosphorylate ITIMs in 
inhibitory cell surface receptors (Xu et al., 2005). 
4.1.3 γ1 in combination with mutation of both Igα  and Igβ   
Similar to the previous report of IgαΔcIgβΔc mice, our data showed no detectable B cells 
in the IgαΔcIgβΔcIgG1i mice, neither in the spleen nor in the peritoneal cavity. We could not 
detect immature B cells in the periphery of those mice either. By different BM staining, we 
were able to explain the complete lack of B cells in those mice since B cell development is 
completely blocked before pre-BII stage. This is identical with the published data of mice 
with a double truncation of Igα and Igβ, in which only pro-B cells are detectable (Reichlin et 
al., 2001). B cell development cannot proceed beyond the pre-BI stage in the absence of the 
cytoplasmic domains of both Igα and Igβ. Our data suggested that signaling through IgG1 
only contributes to the peripheral B cells and IgG1, instead of IgM, is less efficient in the BM 
B cell development. 
4.2 Signals of Smad7 in the B cells immunity 
TGF-β is a central regulator of immune system. It maintains tolerance via the regulation 
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of lymphocyte proliferation, differentiation, and survival (Li et al., 2006a). In vitro studies 
showed that Smad7 is induced by the TGF-β superfamily members and negatively modulates 
TGF-β signaling, thus acting in a negative, autocrine feedback manner (Yoshimura et al., 
2003). To clarify the biological role of Smad7 in lymphocytes in vivo, we have generated a B 
cell-specific Smad7-deficient mouse line (CD19Cre/Smad7flox) and have demonstrated the 
efficient and B cell-specific deletion of Smad7 in CD19Cre/Smad7flox mice. Loss of Smad7 
was also shown in the Smad7ΔexI mice, in which the Smad7 gene was inactivated by replacing 
exon I of Smad7 with the neo resistance cassette (Li et al., 2006b). However, the remaining 
Smad7 5-leader sequence and the inserted neo cassette results in expression of three spliced 
variants that do not exist in wild type mice. The function of the proteins derived from these 
spliced variants remains unclear. Hence, it is hard to determine whether the phenotypes of this 
mouse strain result from deficiency of Smad7 or expression of the spliced variants. In our 
mouse model, the neo cassette was deleted by FRT-induced deletion and the loxP–flanked 
region is base on the whole Smad7 promoter and first exon. Therefore there should be no neo 
cassette and spliced variant left. Moreover, B cell-specific deficiency also avoids the effects 
of Smad7 deletion in other cell types that could mask the phenotype or complicate data 
interpretation. 
Our analysis of CD19Cre/Smad7flox mice reveals several distinct roles of Smad7 in B 
cells. Smad7 was shown to be important for the induction of an IgA response. Also it 
regulates the maintenance of peripheral B cells, because there was a decreased number of B2-
B cells in the peritoneal cavity (PC) and an increased population of germinal center B cells in 
the Peyer’s patches (PP) of the Smad7 mutant mice. 
TGF-β is also a crucial factor for induction of IgA response. It has been shown that 
TGF-β synergizes with other cytokines such as IL-5 or IL-2 for IgA class switch from murine 
LPS-stimulation B cells in vitro. Moreover, TGF-β receptor type II deficient mice (TβΡΙΙ−Β) 
had almost absent IgA levels in the serum, and IgA was not inducible by T cell-dependent 
Ags (Cazac and Roes, 2000). IgA production was also partially blocked in TGF-
β1−deficient mice (van Ginkel et al., 1999). Because the intracellular TGF-β signal is mainly 
inhibited by Smad7, an increase of IgA would also be expected in Smad7-deficient mice. 
Indeed, the Smad7 deficient mice showed a clear enhancement in IgA level of total serum. Ex 
vivo, we found a 3-fold increase of surface IgA+ B cells in the PP of Smad7-deficient mice 
compared to controls. The increased surface IgA+ B cells suggest that the enhanced serum IgA 
of Smad7 deficient mice results from an increase in class switch to IgA in response to TGF-β. 
This was evidenced by the increased in vitro TGF-β/LPS-induced IgA class switch in Smad7-
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deficient B cells. Therefore, Smad7 has a clear role as an inhibitor in TGF-β induced IgA 
class switch recombination, thereby leading to the regulation of serum IgA secretion. In 
addition, the increased surface IgA+ B cells were detected in the PP but not in the spleen of 
Smad7 mutant mice. PP of the GALT are distinct compartments in which specialized 
epithelial M cells deliver antigen from the intestinal lumen, through transcytosis, into direct 
contact with lymphocytes and macrophages (Brandtzaeg and Johansen, 2005). Our finding 
reflects that TGF-β plays a major role in the control of B cell responsiveness in GALT (Cazac 
and Roes, 2000).  
TGF-β directs an LPS-triggered B cell switch to IgA, but inhibits LPS/IL4-triggered 
IgG1 class switch. The increased in vitro IgA class switch is associated with decreased IgG1 
class switch in the TGF-β treated Smad7-deficient B cells compared to controls. Ex vivo, a 
reduced population of surface IgG1+ B cells was also detected in the PP of Smad7-deficient 
mice compared to controls. This is in line with low IgG1 serum levels in the mutant mice. On 
the other hand, we observed an enlarged population of germinal center B cells in the PP of 
Smad7 mutant mice. The reduced population of IgG1+ B cells in the PP of mutant mice 
indicates that this enlargement is not due to the inflammation condition of the individual 
mouse. Since surface IgA+ and IgG1+ B cells locate in the germinal center, the enlarged 
germinal center must be mainly attributed to the increased population of IgA+ B cells in the PP 
of Smad7-deficient mice. 
In vitro data demonstrate that TGF-β inhibits proliferation of B lymphocyte progenitors 
and also induces apoptosis in B lymphocyte progenitors, immature B cells and resting B cells 
(Lomo et al., 1995) (Kee et al., 2001). Thus, a developmental impairment would be expected 
in the TGF-β receptor or inhibitor (Smad7) deficient mice. In contrast, TβΡΙΙ−Β mice exhibit 
a non-impaired B cell development in the BM and periphery except for increased IgA+ B cells 
and B1-B cells in the GALT (Cazac and Roes, 2000). Consistent with the TβΡΙΙ−Β mice, we 
did not detect any impairment of B cell development in the BM and spleen of Smad7-
deficient mice. However, apart from PP B cells, a 2-fold decrease of B-2 B cells was noted in 
the PC of Smad7-deficient mice compared to control mice. Our analysis of in vitro B cell 
survival revealed that this decrease results from the increased TGF-β-induced B cell apoptosis 
in the Smad7-deficient B cells. Thus, Smad7 is also critical for inhibiting the signaling of 
TGF-β-induced apoptosis in B cells.  
In summary, the B cell–specific Smad7 knock-out mouse generally exhibits an opposite 
phenotype as TβΡΙΙ−Β mice. This indicates that Smad7 is a crucial downstream inhibitor in 
TGF-β receptor signaling in B cells. In particular, Smad7 plays an important role in TGF-
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β−dependent regulation of IgA switching. Secretory IgA is known to be important for the 
prevention of microbial infection in the mucosa (Sun et al., 2004). Therefore, it is of interest 
to further investigate in the future how Smad7 functions during a B cell response to 
extrogenous infection, especially the secretory manner of IgA and the disease process related 
to IgA level, by inducing inflammation in the mucosa of our mouse model.  
4.3 BAC strategy for the gene targeting  
The NIK gene targeting project was started from Max von Holleben’s work in which he 
used traditional targeting vector. But the efficiency of targeting ES cells was very low and the 
injection of positive clone fails to give rise to chimeric mice. Therefore, a BAC strategy was 
devised to enhance the targeting efficiency.  
In our experiment, the transfection of ES cells with linearised BAC resulted in more 
than 80% of the picked clones screening positively using an internal probe southern blot. But 
it is hard to make an external probe strategy since the BAC is too long to find suitable cutting 
sites. Semi-quantitative southern blot was performed to resolve this issue. Because 
homologous recombination will give rise to one additional band with the same intensity as 
WT band, the method will determine homologous recombinants based on band intensity. The 
DNA from promising clones was used as a template for PCR that was designed to detect the 
backbone of BAC. The concept is based on the phenomenon that random integration normally 
leads to insertion of the backbone into a random location in the genome. The TK gene and 
DTA gene in the conventional targeting vector are based on the same principle (Yu et al., 
2000). Finally, the result of FISH (fluorescence in situ hybridization) confirmed that the 
quantitative southern blot and the PCR detecting random integration were efficient in finding 
homologously recombined clones. In addition to these two methods, real time PCR is believed 
to be alternative approach that is able to detect the copies of the gene of interest. The design 
of primers for real time PCR should base on the target exon. 
Comparing the BAC targeting strategy with conventional strategy, it becomes clear that 
neither one is free of disadvantages. The major advantage of the conventional targeting 
approach is that it is possible to screen for homologous recombination with standard 
techniques like Southern blotting. Disadvantages are the tedious cloning of the targeting 
vector and the possibility of very low targeting frequencies. On the other hand, the BAC 
Red/ET cloning strategy has several advantages. Once it is established in a lab, it is very fast. 
If the Southern blot strategy has been tested before, a targeting vector can be generated in less 
than three weeks. A second major advantage is that the targeting efficiency is very high, 
which reduces the amount of colonies that have to be screened to less than 100. Third, 
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multiple integration of the BAC into the genome can be of interest because this leads to 
higher expression levels of the construct. Multiple integrations should be detectable in a 
Southern blot screen indicated by a stronger signal for the targeted band than the wt band. 
Therefore BAC strategy provides a very efficient and reliable way to generate knock-in 
mouse model, especially Cre mice. The modified BAC could be directly injected into stem 
cells and transfer to mouse, which save a lot of time from cell culture work and also decrease 
the possibility of harmful stem cells. 
One has to thoroughly balance the advantages and disadvantages of the two approaches. 
Once the BAC Red/ET approach is set-up in the laboratory, it can be a fast and efficient 
approach alternative to the conventional targeting. 
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5 Summary 
IgG1 (γ1), known as surface marker of memory B cells, is characterized with a 
conserved cytoplasmic tail that is lacking in IgM (µ) and IgD (δ) chains (Geisberger et al., 
2003; Neuberger et al., 1989; Reth, 1994). To investigate the physiological role of this 
cytoplasmic tail, a novel mouse strain (IgG1i) was established in which Cγ1 takes place all the 
other CH gene segments. IgG1i mice exclusively express membrane-bound IgG1 in the B 
lineage. On the other hand, it is known that signal transduction through µ and δ chains relies 
entirely on the cytoplasmic tails of the BCR-associated Igα/β heterodimer. To assess whether 
signal-transduction through γ1  is also Igα/β-dependent, we generated the IgαΔcIgG1i mice 
which carry the IgG1 BCR in combination with Igα truncation and the IgβΔcIgG1i mice which 
carry the IgG1 BCR in combination with Igβ truncation. We found that signal of γ1 affects 
peripheral B cell compartment distinctly when combining Igβ truncation or Igα truncation. B 
cells number in IgαΔcIgG1i mice is over ten times as the number in IgαΔc mice. In contrast, 
IgβΔcIgG1i mice did not increase the number of B cells in compared with IgβΔc mice. Our data 
suggested that the increased number of peripheral B cells in the IgαΔcIgG1i mice compared to 
IgβΔcIgG1i mice did not come from an advantage in the BM B cell development, but rather 
from a peripheral influence. Due to the insufficient receptor expression, Igα or Igβ mutant B 
cells were unable to respond to the survival signal of BAFF and exhibit down-regulated 
expression of basal Bcl-XL accordingly. This down-regulation of Bcl-XL is correlated with the 
faster faded away phosphorylation of PLCγ2 and reduced level of IΚBα phosphorylation. 
These findings suggested that the B cell survival signal through γ1 depends on both Igα and 
Igβ but mainly on Igβ which is required for NF-κB-directed Bcl-XL expression. 
B cell-specific Smad7-deficient mouse  
Previous in vitro studies showed Smad7 is induced by the TGF-β superfamily members 
and negatively modulates TGF-β signaling. To clarify the biological role of Smad7 in B-
lymphocytes, we have generated a B cell-specific Smad7-deficient mouse line 
(CD19Cre/Smad7flox). Our data indicated that Smad7 plays an important role in TGF-β-
dependent regulation of IgA switching. Also it regulates the maintenance of B-2 B cells in the 
peritoneal cavity. In summary, our findings suggest that Smad7 is a crucial downstream 
inhibitor in TGF-β receptor signaling in B cells. 
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6 Zusammenfassung 
Der Zelloberflächenmarker IgG1 auf Memory B Zellen ist durch eine konservierte 
zytoplasmatischen Domäne, die bei den IgM und IgD Ketten fehlt, charakterisiert. Um die 
Rolle dieser zytoplasmatischen Domäne zu untersuchen, wurde die IgG1i Maus generiert, 
welche die Cγ1 Kette anstatt der restlichen Ch Segmente trägt/exprimiert. Diese Mäuse 
expremieren ausschließlich IgG1 in B Zellen. Die Signaltransduktion der B Zell Rezeptoren 
(BCR) erfolgt über die µ bzw. γ Kette in Kombination mit den Heterodimeren Igα/β. Um 
herauszufinden ob die Signaltransduktion über γ1 zusätzlich abhängig von Igα/β ist, wurden 
IgαΔcIgG1i Mäuse generiert, die den IgG1 BCR in Kombination mit Igα Mutation tragen und 
IgβΔcIgG1i Mäuse, welche den IgG1 BCR in Kombination mit einer Igβ Mutation tragen. Mit 
Hilfe dieser Mausmodelle konnten wir zeigen, dass γ1 ausschließlich in Kombination mit Igα 
oder Igβ Einfluss auf das periphere B Zell Kompartment hat. Die Anzahl der B Zellen in 
IgαΔcIgG1i Mäusen ist 10 fach erhöht verglichen mit der Anzahl von B Zellen in IgαΔc 
Mäusen. In IgβΔcIgG1i ist die B Zell Zahl im Vergleich mit IgβΔc Mäusen unverändert. Diese 
Daten deuten darauf hin, das die divergenten Effekte der γ1 Signal Transduktion im 
peripheren B Zell Kompartment der IgαΔcIgG1i und der IgβΔcIgG1i Mäuse vom Überleben 
oder von der Proliferation der B Zellen in der Peripherie abhängig ist. Auf Grund der 
insuffizienten Expression der Rezeptoren, reagieren Igα oder Igβ mutierte B Zellen nicht auf 
den Überlebensfaktor BAFF und regulieren die basale Expression von Bcl-XL herunter. Die 
verminderte Expression von Bcl-XL korreliert mit der beschleunigten PLCγ2 
Phosphorylierung und einer verminderten Phosphorylierung von IkBα. Diese Ergebnisse 
lassen eine Abhängigkeit des γ1- B Zell Überlebenssignal von Igα und Igβ vermuten, wobei 
Igβ eine wichtigere Rolle auf Grund des Einflusses auf die NF-κB abhängigen Expression 
von Bcl-XL zuteil wird.  
Vorangegangene in vitro Versuche haben gezeigt, dass Smad7 von Mitgliedern der 
TGF-β Superfamilie induziert wird und die Signaltransduktion von TGF-β negativ reguliert. 
Um die biologische Funktion von Smad7 in B Lymphozyten zu untersuchen, wurde eine 
Mauslinie etabliert, (CD19Cre/Smad7flox) in der Smad7 ausschließlich in B Zellen deletiert 
ist. Unsere Ergebnisse zeigen, dass Smad7 eine wichtige Rolle in der TGF-β abhängigen 
Regulation von IgA hat. Des Weiteren reguliert Smad7 Homöostase des B-2 B Zell Pools im 
Peritoneum. Zusammenfassend lässt sich aus den in dieser Arbeit präsentierten Daten 
schließen, dass Smad7 ein wichtiger Inhibitor in B Zellen ist, der unterhalb des TGF-
β Rezeptors fungiert. 
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